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This study focuses on the epidemiology in children with kidney diseases 
and tries to add to the existing knowledge about its determinants, in 
particular Roma ethnicity, and its outcomes. The first chapter mainly 
introduces the existing knowledge about chronic kidney disease in 
children, describes its incidence and prevalence and underlines its 
importance from a perspective of public health with a focus on populations 
at risk. Furthermore etiologies, risk factors and finally outcomes of CKD 
are stressed in this chapter. This first chapter also presents the further 
structure of this thesis. 
1.1 Chronic kidney disease and public health 
For long time no clear definition or a uniform name for impaired renal 
function existed. It was only in 2002 when the Kidney Disease Outcomes 
Quality Initiative (KDOQI) organization for the first time defined and 
classified CKD (National Kidney Foundation 2002; Levey et al. 2005). The 
current guideline of Kidney Disease Improving Global Outcomes (KDIGO) 
defines CKD as “abnormalities of kidney structure or function, present 
for >3 months, with implications for health” (Kidney Disease: Improving 
Global Outcomes 2012; Levey et al. 2011). This report recommends classify 
CKD based on cause, glomerular filtration rate category, and albuminuria 
category.
Until relatively recently end-stage renal disease (ESRD), the most 
severe stage of chronic kidney disease (CKD), was uniformly fatal. Only 
after 1943, when Willem Kolff introduced his unique invention, the 
hemodialysis machine, enabling purification of blood of individuals 
with failed kidneys, life with ESRD became possible. The scientific and 
technologic improvements during the second half of the 20th century 
led to a wide establishment of renal replacement therapy (RRT) on a 
routine basis as a life-sustaining option for ESRD patients. Treating ESRD 
however imposes a large burden on patients, the health care system, and 
society, including high associated costs. From a public health perspective 
this is a phenomenon of a shift from premature death to years lived with 
disability what imposes new challenges on the health system (Murray et 
al. 2012; Foley and Collins 2007). For instance in India, where less than 
1% of gross domestic product is spent on healthcare, ESRD care has a low 
priority resulting in many patients to quit their maintenance dialysis due 
to the lack of funds (Sakhuja and Sud 2003).
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According to the 2010 Global Burden of Disease study CKD is among 
top 10 leading causes of death and ranks 29th with regard to disability-
adjusted life-years (Go et al. 2004; Murray et al. 2012; Murray et al. 2013). 
Rising numbers of incident and prevalent CKD and ESRD patients are 
reported from large registries e.g. the United States Renal Data System 
(USRDS) or the Australia & New Zeeland Dialysis and Transplantation 
Registry (ANZDATA) (Coresh 2005; Glassock and Winearls 2008). From 
a perspective of global disease burden there is a trend of a shift in 
middle- and high-income countries from infectious to non-communicable 
diseases (Murray et al. 2012). Data from the registries also indicate that 
the occurrence of ESRD is disproportionately high among certain ethnic 
minorities, and among individuals with certain clinical conditions e.g. 
low nephron endowment (Lopes et al. 1995; Tarver-Carr et al. 2002; Crews 
et al. 2010; Patzer et and McClellan 2012). 
The pediatric population suffering from ESRD is growing as well, 
mainly due to the significantly improved survival of formerly lethal 
diseases. This is particularly true for the high-income countries of Europe, 
Japan, North America and Australia, where children with ESRD have 
access to RRT (Harambat et al. 2012). While the occurrence of ESRD is 
relatively well described in certain countries e.g. the United States of 
America, the United Kingdom and the Netherlands, less information is 
available on the epidemiology of ESRD in other (European) countries e.g. 
Slovakia, even more when it comes to ethnic minorities. This is probably 
a consequence of the absence of official national or regional registries in 
most of these countries, including Slovakia (Warady and Chadha 2007). 
The numbers of ESRD children are just a fraction of those of adults, 
on the other hand ESRD children are just a tip of an iceberg in the ocean 
of CKD children which may progress into symptomatic stages of the 
disease later in adulthood. This is particularly alarming in the context 
of epidemics of (childhood) obesity which was shown to have a strong 
influence on the occurrence of CKD (Adelman et al. 2001; Hedley et al. 
2004). Action plans are called for, in particular regarding prevention, 
but this requires a clear understanding of the occurrence and outcomes 
of the disease, antecedent risk factors, and appropriate treatments for 
populations at risk. The impact of CKD on the individual and on public 
health is thus even more apparent in children.
1.2 Determinants of CKD occurrence in children and its  
 progression into ESRD
The main causes of CKD in children include congenital and hereditary 
diseases. The most common ones are congenital anomalies of kidneys 
and the urinary tract; these explain almost half of the CKD causes in 
children. Cystic diseases followed by glomerulonephritis come after 
9(U.S. Renal Data System 2013; Australia and New Zeeland Dialysis 
and Transplantation Registry 2013; Pruthi et al. 2013). Shares varies 
worldwide with glomerulonephritides being significantly more common 
in developing countries (Hurtado and Johnson 2005).
Despite the different etiologies, once chronic kidney disease develops, 
the subsequent response of the failing kidney is similar. An increasing 
body of evidence suggests that progression of CKD may be largely 
determined by pathophysiologic mechanisms that are unrelated to the 
activity of the initial disease. These include among others hyperfiltration 
with subsequent intraglomerular and systemic hypertension, impairment 
of calcium-phosphate metabolism as well as acidobase imbalance, 
secondary anemia, hyperlipidemia, and systemic inflammation (Wuhl 
and Schaefer 2008). The kidney initially adapts to this damage by 
increasing the filtration rate in the remaining normal nephrons, a process 
called adaptive hyperfiltration. As a result, patients with mild CKD often 
have a normal or near-normal serum creatinine concentration. Adaptive 
hyperfiltration, although initially beneficial, appears to result in long-
term further damage to the glomeruli of the remaining nephrons, which 
is manifested by systemic hypertension and albuminuria/proteinuria. 
The irreversibility of this process appears to be one of the key players 
responsible for the progression of CKD and development of ESRD 
(Brenner and Mackenzie 1997). It is necessary to add that the occurrence 
of CKD and subsequent rate of loss of renal function are highly variable 
among individuals with the same underlying cause of renal injury or 
degree of functional impairment. The individual variability of risk reflects 
the multifactorial nature of the biological mechanisms that are involved in 
the underlying disease process (McClellan and Flanders 2003).
The Brenner theory of hyperfiltration has highlighted low nephron 
endowment as a significant risk factor for developing hypertension and 
consequent renal failure (Brenner and Mackenzie 1997). According to 
this hypothesis low nephron endowment leads to increased filtration 
rate per nephron with consequent premature damage to the remaining 
nephrons what generates systemic hypertension and puts patients on 
a higher risk for renal failure.  Epidemiologic studies supported this 
hypothesis by showing a close association between the risk of CKD/ESRD 
and certain ethnic populations with low nephron endowment (Nelson 
et al. 1996; McDonald et al. 2010). For instance the incidence of ESRD in 
Australian Aborigines is significantly higher compared to non-indigenous 
inhabitants, the age-adjusted rate reaches 20-fold in some age categories 
(McDonald et al. 2010). Similarly Indo-Asian immigrants in the United 
Kingdom (UK) have approximately 3–5 times higher incidence rates of 
ESRD compared to the majority population in the UK (Lightstone 2003). 
Ethnic differences regarding the occurrence of CKD/ESRD have 
been shown for many parts of the world, but evidence fully lacks for 
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Roma who represent a significant minority in Europe. The risk for kidney 
diseases in Roma could be hypothesized to be high, considering the high 
occurrence of ESRD in India where Roma may have come from (Sakhuja 
and Sud 2003; Modi and Jha 2006; Agarwal and Srivastava 2009) and 
among the Indian immigrants in Europe (Lightstone 2003). 
1.3 Prognosis of CKD/ESRD in children
Pediatric end-stage renal disease (ESRD) patients nowadays frequently 
survive until adulthood and beyond, but their overall mortality remains 
high. If reaching adulthood, the mean life-expectancy of dialysis patients is 
still 40-50 years less, and of transplant patients 20-25 years less than an age- 
and race-matched population (U.S. Renal Data System 2011). According to 
these data from the United States 22-32% of all these premature deaths 
is explainable by cardiovascular disease. Infectious diseases may explain 
another about 20% (U.S. Renal Data System 2011; Mitsnefes 2012). 
Although the long-term survival of children with ESRD has 
increased during the past decades, the quality of life (QoL) of these patients 
remains poor (Goldstein et al. 2006; Kaptein et al. 2010; Copelovitch et al. 
2011). This influences not only the patient’s current life but it may also 
influence the patient’s functioning in the future in terms of decreased 
school attainment, disability and thus lower ability to find a job in the 
future. Published research has shown that many adults with childhood-
onset kidney disease have significant impairments in educational, social, 
and physical functioning (Rosenkranz et al. 1992; Rosenkranz et al. 2005). 
Evidence-based clinical practice guidelines support early recognition 
and treatment of CKD–related complications to improve growth and 
development and, ultimately, the QoL in children with this chronic 
condition (National Kidney Foundation 2002; Kidney Disease: Improving 
Global Outcomes 2013).
A decreased GFR is associated with complications in virtually all 
organ systems. High blood pressure, anemia, malnutrition, mineral bone 
disease, neuropathy, and resultant decreased overall functioning and well-
being are the main characteristics of CKD children (Wuhl and Schaefer 
2008). In looking more closely at cardiovascular complications, which 
explain most of the premature deaths, it is important to stress that nearly 
50% of all these patients suffer from left ventricular hypertrophy (LVH) 
and life-threatening vascular changes (Groothoff 2005). Cardiac arrest is 
the most common cause of death, followed by arrhythmia, cardiomyopathy 
and cerebrovascular disease (U.S. Renal Data System 2011). Certainly 
patients with CKD should be considered as the highest risk group for 
subsequent cardiovascular disease (CVD) events. The excess risk of CVD 
may be attributed to two big groups of risks factors, namely ‘uremic’ or 
‘CKD-related’ and ‘traditional’ CVD risk factors which are significantly 
11
more prevalent in a population of CKD individuals. Further studies are 
needed to shed more light on the risk factors to improve survival and 
potentially QoL of these patients. 
1.4 Primary aim of the thesis and research questions
The primary aim of this thesis is to explore the epidemiology of CKD and 
some of its determinants and outcomes in children with specific attention 
for ethnic issues. As a first step this study will focus on the incidence and 
prevalence of the most severe stage of CKD in Slovakia compared to the 
remainder of Europe, and its changes over the past decade. Furthermore 
it will analyze the etiology of ESRD among children. Then, we will deal 
with ethnic issues focusing on the relative risk (RR) of ESRD and on the 
share of ethnic minority within CKD patients overall.  Additionally we 
will analyze the share of the Roma ethnic minority according to primary 
renal diseases. Next, we will study solitary kidney patients, a population 
with (congenital) reduction in renal mass, to clarify if having only one 
(functioning) kidney puts them at risk for CKD/ESRD and finally we will 
focus on outcome of CKD and ESRD patients focusing on cardiovascular 
complications, especially LVH (Figure 1.1).
The five research questions listed below are formulated based on the 
model as depicted in Figure 1.1.
Figure 1.1 Model describing relationship between risk factors and outcomes of CKD according to 
the research questions (RQ1-RQ5)
9 
 
A decreased GFR is associated with complications in virtually all organ systems. High blood pressure, 
anemia, malnutrition, mineral bone disease, neuropathy, and resultant decreased overall functioning and well-
being are the main characteristics of CKD children (Wuhl and Schaefer 2008). In looking more closely at 
cardiovascular complications, which explain most of the premature deaths, it is important to stress that nearly 50% 
of all these patients suffer from left ventricular hypertrophy (LVH) and life-threatening vascular changes (Groothoff 
2005). Cardiac arrest is the most common cause of death, followed by arrhythmia, cardiomyopathy and 
cerebrovascular disease (U.S. Renal Data System 2011). Certainly patients with CKD should be considered as the 
highest risk group for subsequent cardiovascular disease (CVD) events. The excess risk of CVD may be attributed to 
two big groups of risks factors, namely ‘uremic’ or ‘CKD-related’ and ‘traditional’ CVD risk factors which are 
significantly more prevalent in a population of CKD individuals. Further studies are needed to shed more light on 
the risk factors to improve survival and potentially QoL of these patients.  
 
1.4 Primary aim of the thesis and research questions 
The primary aim of this thesis is to explore the epidemiology of CKD and some of its determinants and outcomes in 
children with specific attention for ethnic issues. As a first step this study will focus on the incidence and 
prevalence of the most severe stage of CKD in Slovakia compared to the remainder of Europe, and its changes over 
the past decade. Furthermore it will analyze the etiology of ESRD among children. Then, we will deal with ethnic 
issues focusing on the relative risk (RR) of ESRD and on the share of ethnic minority within CKD patients overall.  
Additionally we will analyze the share of the Roma ethnic minority according to primary renal diseases. Next, we 
will study solitary kidney patients, a population with (congenital) reduction in renal mass, to clarify if having only 
one (functioning) kidney puts them at risk for CKD/ESRD and finally we will focus on outcome of CKD and ESRD 
patients focusing on cardiovascular compl cations, especially LVH (Figure 1.1). 
The five research questions listed below are formulated based on the model as depicted in Figure 1.1. 
 
 























Risk factors Outcomes 
Research question 1:
1a. What are the actual incidence and prevalence rates of ESRD and RRT 
in Slovak children?
1b. What are the differences in these rates regarding 2003–2009 compared 
with those from earlier epidemiological surveys carried out in Slovakia?
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1c. What are the incidence and prevalence rates of ESRD and RRT in Slovak 
children compared with those of children from other European countries?
1d. What is the etiology, i.e., primary renal diseases and treatment modes, 
compared with earlier studies on Slovak children and with children from 
other European countries?
Research question 2:
What is the difference in occurrence of ESRD between Roma and non-
Roma and what is the relative risk (RR) of Roma for ESRD by age?
Research question 3:
What is the share of Roma and non-Roma in a tertiary nephrology clinic 
for children compared with that in the general population, and secondly 
what is the share of Roma and non-Roma regarding early signs of primary 
renal diseases (PRD) and specific PRD?
Research question 4:
What is the occurrence of renal injury as defined by presence of severely 
increased albuminuria, hypertension and/or decrease of glomerular 
filtration rate (GFR) <60ml/min/1.73m2 in solitary functioning kidney 
(SFK) children? 
Research question 5:
What is the change in left ventricular hypertrophy in ESRD children 
before and after transplantation?
1.5 The structure of the thesis
The thesis consists of 8 chapters. The Introduction (Chapter 1) provides 
information about public health aspects of CKD, CKD in children and its 
prognosis. Furthermore, a model and five research questions regarding 
the epidemiology of CKD, risk factors and outcomes are formulated. 
Chapter 2 ‘Data sources, measures and statistical analyses’ deals with data 
sources, measures and statistical analyses. In Chapter 3 ‘End-stage renal 
disease in Slovak children: epidemiology from a European perspective’ 
the epidemiology of ESRD in children is discussed from a European 
perspective. Chapter 4 ‘End-stage renal disease among Roma and non-
Roma: Roma are at risk’ deals with ethnic differences in the relative 
risk of ESRD of children and adults. In Chapter 5 ‘Kidney diseases in 
Roma and non-Roma children from eastern Slovakia: are Roma children 
at risk?’ ethnic issues are studied in a population of CKD children of all 
stages visiting the outpatient department of the pediatric clinic. Chapter 
6 ‘Solitary functioning kidney in children – a follow-up study’ focuses 
on the outcome of patients with one functioning kidney from childhood. 
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Chapter 7 ‘Left ventricular hypertrophy in children and adolescents before 
and after renal transplantation’ explores the outcome of CKD patients 
from a perspective of the cardiovascular consequences particularly left 
ventricular hypertrophy. Finally, the Discussion (Chapter 8) presents the 
condensed outcomes of this study, discusses them in the framework of the 
existing knowledge, argues their strengths and weaknesses, goes into their 
implications for practice and offers new possibilities for further research. 
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Data sources, measures and statistical 
analyses
This chapter presents an overview of the data sources, measures and 
statistical analyses used within this thesis. 
2.1 Samples and procedures 
Several samples were used in this thesis as presented in Table 2.1, 
indicating the chapters for which they were used. To a certain extent these 
samples overlapped as all of them consisted of dialyzed and transplanted 
children as well as lower stages CKD (1-4 CKD) children from a tertiary 
center for pediatric nephrology in Kosice, Slovakia, although the sample 
sizes differ as well as the period covered. Additionally in Chapter 3, all 
pediatric patients from the other parts of Slovakia were included, and in 
Chapter 4 patients in care of nephrologist for adults (from all Fresenius 
Nephrology Care centers in Slovakia) were analyzed.  
Table 2.1 Basic characteristics of the research samples
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the region of 
Eastern Slovakia 
Age, years±SD (range) 12.0 (0-18) 59.8±14.7 11.3±6.3 11.8±5.2 11.3±3.6 
*All samples are described in detail in the related Chapters 
ESRD: end-stage renal disease; RRT: renal replacement therapy; ECHO: echocargiography 
 
2.2 Measures 
In the various chapters of this thesis, variables were used on sociodemographic background and on clinical 
characteristics of the patients.   
*All samples are described in detail in the related Chapters
ESRD: end-stage renal disease; RRT: renal replacement therapy; ECHO: echocargiography
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2.2 Measures
In the various chapters of this thesis, variables were used on 
sociodemographic background and on clinical characteristics of the 
patients.  
2.2.1 Sociodemographic background
These included age, gender and ethnicity. Age was treated as continual 
variable while ethnicity was categorized into majority and Roma based 
on the self-identification of the patient or his/her parent/guardian, the 
decision of the physician and in case of a mismatch the decisive decision 
of the head nurse.
2.2.2 Clinical characteristics
Medical determinants were retrieved from medical files. These included 
the diagnosed primary renal disease (PRD), type of dialysis treatment 
(peritoneal dialysis or hemodialysis) and type of transplantation (from 
living or deceased donor) and clinical measurements like blood pressure as 
well as laboratory findings (serum creatinine and albuminuria). Estimated 
glomerular filtration rate (eGFR) (in milliliters per minute per ideal body 
surface area) was calculated using the Schwartz formula (Chapter 6 and 
7) (Schwartz et al. 1976). Chronic kidney disease (CKD) stages from 1 
to 5 as well as severity of albuminuria were classified as recommended 
by the Kidney Disease Improving Global Outcome (KDIGO) guidelines 
(Figure 2.1; Kidney Disease: Improving Global Outcomes 2013). Incidence 
and prevalence of renal injury and ESRD/RRT as well as mortality of the 
patients were calculated.
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Several statistical methods were used in this thesis to analyze data and all 
of them were performed using the statistical software package IBM SPSS 
for Windows, version 16.0 and 20.0 (IBM, Chicago, Illinois, USA) or SAS 
9.2 (SAS Institute Inc., Cary, North Carolina, USA). A detailed description 
of the statistical analyses used to explore the research questions are 
addressed in the individual chapters of this thesis.  
The chi-square test and the T-test were used to assess the statistical 
significance of the differences between groups of categorical and continual 
variables respectively. Kaplan-Meier analysis was used to describe renal 
injury-free survival. Furthermore, the Chi-square and Fisher tests of 
proportions were used to determine differences in shares among different 
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End-stage renal disease in Slovak 
children: epidemiology from a European 
perspective
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European Journal of Pediatrics (2011) 170: 1445-1451
Abstract
The aim of this study was to examine the occurrence of end-stage renal 
disease (ESRD) in Slovak children, to compare it with earlier Slovak data 
and with data from other European countries, and to explore etiology. 
Over the years 2003-2009, data on the incidence and prevalence of all cases 
of ESRD in children from all four Slovak tertiary pediatric centers were 
collected. The data were compared with two earlier Slovak studies and 
with European data from the European Society of Paediatric Nephrology. 
The median annual incidence rate of ESRD in Slovak children under 15 
years of age was 6.6 per million age-related population (pmarp). The 
prevalence rate on 31st December 2009 was 24.1 pmarp. Compared with the 
last study (18.6 pmarp), the differences were not statistically significant. 
The comparison with neighboring countries and with the European 
average shows no significant difference in incidence, while prevalence 
is significantly lower compared to neighboring Austria and some other 
(mostly western) European countries as well as the European average. In 
conclusion, during the past decade, the incidence and prevalence rates of 
ESRD in Slovak children have remained stable. Compared to the European 
average, the prevalence in Slovak children is significantly lower.




The pediatric population suffering from end-stage renal disease (ESRD) 
in Europe is growing. Children with formerly lethal diseases nowadays 
survive until adulthood and beyond (Reiss et al. 1996). The reported 
number of children on renal replacement therapy (RRT) has almost 
tripled during a relatively short period of 15 years (Mehls et al. 1996, van 
der Heijden et al. 2004, van Stralen et al. 2010).     
Nevertheless, reliable epidemiological information on ESRD and 
RRT in European children is not easy to obtain. One source of information 
is the annual reports of the European Renal Association – European 
Dialysis Transplantation Association (ERA-EDTA), but these reports are 
somewhat limited since data are often lacking, especially from Central 
and Eastern European countries. This is probably a consequence of 
the absence of official national or regional registries in most of these 
countries, including Slovakia (Warady and Chadha 2007). In 2007, the 
European Society of Paediatric Nephrology (ESPN) began collecting data 
on pediatric renal replacement therapy (RRT) patients exclusively on the 
basis of national or large regional registries in an attempt to solve the 
problem of insufficient information.
In Slovakia, only two pediatric epidemiologic studies on this topic 
have been published so far. The first such study was by Zvara et al. in 
the years 1975-1977 and included children under the age of 15 years 
with chronic kidney disease (CKD) (Zvara et al. 1978). As a result of 
unavailability of dialysis and transplantation, the prevalence of RRT at 
that time was only 1.5 per million age-related population (pmarp) under 
15 years of age (0.4 per million total population-pmtp). The next study 
on Slovak children was done in the year 2002 by Podracka et al., but this 
study was done on CKD children in a different age category (under 18 
years of age) revealing a prevalence rate of 29.3 pmarp for this age group 
(7.4 children pmtp) (Podracka and Kovacs 2004). 
Up to now, a national register with the potential of monitoring health 
care of pediatric end-stage renal disease patients has not been established 
in Slovakia. Therefore, the main aims of the present study are:
1. To evaluate the actual incidence and prevalence rates of ESRD and 
RRT in Slovak children; 
2. To compare the results regarding 2003-2009 with those from earlier 
epidemiological surveys carried out in Slovakia;
3. To compare the incidence and prevalence rates of ESRD and RRT in 
Slovak children with those of children from other European countries;
4. To compare the etiology, i.e. primary renal diseases and treatment 





According to a new ERA-EDTA policy, this epidemiologic study evaluated 
data from all four tertiary centers for pediatric nephrology in Slovakia 
(Bratislava, Košice, Banská Bystrica and Martin) treating all pediatric RRT 
patients (Briggs 2000). The total sample consisted of 83 patients below 
the age of 19 years (32 girls, 51 boys) treated for ESRD in Slovakia in the 
period 1 January 2003 - 31 December 2009. Population data were obtained 
from the Statistical Office of the Slovak Republic.
Procedure and measures
Data were collected using questionnaires sent to the heads of all four 
pediatric dialysis and transplantation centers in Slovakia. For each patient 
age, gender and clinical variables were retrieved. Clinical variables were 
derived from the medical files by one of the authors (GK) regarding the 
primary renal disease, the date and mode of the first RRT (peritoneal 
dialysis (PD), hemodialysis (HD) or preemptive transplantation), and 
changes in treatment including date and type of each transplantation 
(preemptive or non-preemptive, from a living or deceased donor). The 
primary renal diseases were recorded as diagnosed by all four centers in 
Slovakia and divided into the categories according to ERA-EDTA (ERA-
EDTA Registry 2008).
For comparison of incidence and prevalence rates of RRT with other 
European countries on the basis of ESPN datasets, the upper age limit was 
set at 14 years. Patients were divided into 5-year categories (0-4, 5-9, 10-14). 
For complete analysis of the Slovak situation, we added an extra category 
of 15-18-year-old children, as these patients are considered pediatric 
(under 19 years old) in Slovakia and other countries. 
Incidence and prevalence rates were calculated as pmarp and pmtp 
in the different age categories (0-4, 5-9, 10-14, 15-18). Prevalence rates 
were expressed as the number of ESRD patients alive and on RRT on 
31 December of each year. Data on RRT from other European countries 
were derived from ESPN/ERA-EDTA annual reports (ESPN/ERA-EDTA 
Registry 2009, ESPN/ERA-EDTA Registry 2010).
Statistical analyses
Descriptive data regarding incidence and prevalence rates of RRT from 
2003 to 2009 were presented. Poisson regression was used to find significant 
differences between the last study from 2002 and actual data from 2009. 
Differences between Slovakia and neighboring countries were compared 
over the years 2007-2008 using test of proportions. The differences were 




Between 1 January 2003 and 31 December 2009, 52 new patients reached 
ESRD before the age of 19 and initiated RRT in Slovakia. The median age 
of the patients at the start of RRT was 12 years, and the range was 0-18 
years. The male/female ratio of the patients was 1.58.
Age distribution and incidence and prevalence rates
The largest portion of the patients (n=20) was aged 10 to 14 years when 
they initiated RRT; 18 patients were 15 to 18 years old; and six were younger 
than age of 5 years at the time of RRT initiation (Table 3.1). The median 
annual incidence rate of RRT (during the study period 2003-2009) was 6.6 
pmarp under age 15 years (1.5 pmtp). The current prevalence rate of RRT 
in Slovak children under 15 years old (measured on 31 December 2009) 
was found to be 24.1 pmarp (3.7 pmtp). Table 3.1 shows the incidence and 
prevalence rates in detail during the whole study period. The average 
mortality of patients under the age of 15 years on RRT during the whole 
period was 1.3%. 
Comparison with earlier Slovak epidemiological surveys
In the first Slovak study, done in 1977 by Zvara et al., only the prevalence 
rate under the age of 15 years was explicitly described (1.5 pmarp, 0.4 
pmtp) (Zvara et al. 1978). The study performed in 2002 presented data 
regarding children under the age of 18 years (Podracka and Kovacs 2004). 
To allow for a direct comparison, we recalculated the rates for children 
under the age of 15 years. The incidence rate was then 4.1 pmarp under 
15 years (0.7 pmtp), and the prevalence rate 18.6 pmarp under 15 years 
(3.2 pmtp). A slightly positive trend both for incidence and prevalence is 
currently present, although the differences between 2002 and 2009 are not 
statistically significant.
Slovakia compared to other European countries
The comparison of incidence and prevalence of RRT among Slovak 
children with children from other European countries using data 
published by ESPN in 2009-2010 for the years 2007-2008 is presented in 
Table 3.2. The comparison with Slovakia’s neighboring countries and with 
the European average shows no significant difference in incidence. The 
Slovak prevalence does not differ than that of most of its neighbors, but it 
is significantly lower compared with neighboring Austria. The same holds 
true in the comparison of Slovak prevalence with some other (mostly 
western) European countries as well as the European average.
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over the years 2003-2009
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Table 3.1 Incidence and prevalence rates of RRT in Slovak children according to age and gender over the years  
2003-2009 
n.a. not available 
 
 
Total Gender Age groups 
0-18 Girls Boys 0-4 5-9 10-14 15-18 
n [pmarp] n [pmarp] n [pmarp] n [pmarp] n [pmarp] n [pmarp] n [pmarp] 
Incidence        
 2002 n.a. n.a. n.a. 0 [0.0] 1 [3.2] 3 [7.7] n.a. 
 2003 6 [4.6]  2 [3.2] 4 [6.1] 0 [0.0] 1 [3.3] 2 [5.2] 3 [8.9] 
 2004 9 [7.2] 4 [6.6] 5 [8.2] 2 [7.7] 1 [3.4] 4 [10.9] 2 [6.1] 
 2005 8 [6.6] 2 [3.7] 6 [9.6] 2 [7.7] 1 [3.5] 5 [14.3] 0 [0.0] 
 2006 6 [5.1] 5 [9.3] 1 [1.6] 0 [0.0] 2 [7.8] 2 [6.0] 2 [6.3] 
 2007 9 [8.3] 4 [7.6] 5 [9.0] 1 [3.8] 0 [0.0] 3 [9.5] 5 [16.2] 
 2008 4 [3.8] 3 [5.8] 1 [1.8] 1 [3.7] 1 [3.8] 1 [3.3] 1 [3.3] 
 2009 10 [8.9] 1 [1.8] 9 [15.7] 0 [0.0] 2 [7.7] 3 [10.3] 5 [17.3] 
 Median 2003-2009 8 [6.6] 3 [5.8] 5 [8.2] 1 [3.7] 1 [3.5] 3 [9.5] 2 [6.3] 
Prevalence 
 2002 n.a. n.a. n.a. 1 [3.8] 6 [19.1] 11 [28.4] n.a. 
 2003 35 [27.3] 13 [20.7] 22 [35.1] 1 [3.8] 3 [10.0] 9 [23.6] 22 [64.9] 
 2004 41 [32.8] 14 [23.0] 27 [44.3] 1 [3.9] 6 [20.6] 9 [24.5] 25 [75.9] 
 2005 43 [35.3] 14 [23.6] 29 [48.8] 2 [7.7] 6 [21.1] 12 [34.3] 23 [71.4] 
 2006 42 [35.4] 18 [31.1] 24 [41.4] 1 [3.8] 8 [29.1] 14 [42.1] 19 [59.9] 
 2007 44 [37.9] 18 [31.8] 26 [46.0] 2 [7.5] 6 [22.5] 15 [47.3] 21 [68.0] 
 2008 39 [34.3] 20 [36.0] 19 [34.2] 3 [11.0] 5 [19.1] 12 [39.8] 19 [62.9] 
 2009 40 [35.7] 18 [32.9] 22 [40.3] 2 [7.1] 4 [15.4] 14 [48.1] 20 [69.1] 

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































The distribution of primary diseases leading to ESRD in Slovak children 
between 1 January 2003 and 31 December 2009 is shown in Table 3.3. 
Congenital anomalies of the kidneys and urinary tract (CAKUT) with 
kidney (hypo)dysplasia comprised the major cause. Cystic diseases 
were the next in importance. The predominance of congenital and 
hereditary disorders as a leading cause of ESRD compared with acquired 
nephropathies was evident. 
The distribution of primary diseases could not be compared 
directly with previous studies because the etiology in those studies was 
only described in regard to all CKD patients but not regarding those in 
ESRD separately. Regarding all CKD patients, the reported distribution 
of primary diseases was: CAKUT 52.4%, hereditary disorders 14.3%, 
glomerular diseases 28.6%, interstitial nephritides 4.8% in 1977; CAKUT 
37.5%, hereditary disorders 26.5%, glomerular diseases 11.5%, interstitial 
nephritides 18.5% in 2002. 
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Table 3.3 Etiology of ESRD in new patients (cohort 2003-2009) 
Etiology 
Total Gender 
0-18 Girls Boys 
n (%) n (%) n (%) 
1. CAKUT 18 (34.6) 5 (23.9) 13 (42.0) 
     Renal hypo-/dysplasia  8 (15.3) 1 (4.8) 7 (22.7) 
     Vesico-ureteric reflux 3 (5.8) 2 (9.5) 1 (3.2) 
     Obstructive uropathy 7 (13.4) 2 (9.5) 5 (16.1) 
          Urethral valve 0 (0.0) 0 (0.0) 0 (0.0) 
          Obstruction without valve 6 (11.5) 1 (4.8) 5 (16.1) 
          Neurogenic bladder 1 (1.9) 1 (4.8) 0 (0.0) 
2.  Cystic disease 10 (19.2) 3 (14.4) 7 (22.7) 
     Polycystic kidney disease 4 (7.7) 1 (4.8) 3 (9.7) 
     Juvenile nephronophtisis 4 (7.7) 2 (9.5) 2 (6.5) 
3. Hereditary nephropathy 5 (9.6) 3 (14.4) 2 (6.5) 
     Alport syndrome 2 (3.8) 2 (9.5) 0 (0.0) 
4. Glomerulonephritis 8 (15.4)  5 (23.9) 3 (9.7) 
     FSGS 5 (9.6) 3 (14.3) 2 (6.5) 
5. HUS 1 (1.9) 1 (4.8) 0 (0.0) 
6. Vasculitis 2 (3.8) 0 (0.0) 2 (6.4) 
7. Miscellaneous  6 (11.5) 3 (14.4) 3 (9.7) 
8. Unknown 2 (3.8) 1 (4.8) 1 (3.2) 
Total 52 (100.0) 21 (100.0)  31 (100.0) 
ESRD: end-stage renal disease, CAKUT: congenital anomalies of kidneys and urinary tract, HUS: hemolytic-uremic syndrome, 
FSGS: focal segmental glomerulosclerosis 
 
ESRD: end-stage renal disease, CAKUT: congenital anomalies of kidneys and urinary tract,  
HUS: hemolytic-uremic syndrome, FSGS: focal segmental glomerulosclerosis
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Treatment mode
During the study period, 27 patients (51.9%) (younger than 19 years 
old) started RRT on PD and 24 patients (46.2%) started their RRT on 
HD. Only one patient (1.9%) was transplanted preemptively. Out of all 
the first transplantations 22.0% were from living-related donors. In 
previous Slovak surveys initial treatment modalities were not described 
(Zvara et al. 1978, Podracka and Kovacs 2004). Compared to published 
data on the overall proportion of preemptive transplantations in Europe 
(15.1%), the proportion of preemptive transplantations in Slovak children 
is significantly lower. Regarding the prevalent treatment modalities 
measured on 31 December 2008 the proportion of HD patients (n=8; 
20.5%) does not significantly differ from the ERA-EDTA data (n=180; 
13.1%), and the proportion of PD patients (n=12; 30.8% vs n=100; 7.3%) is 
significantly higher and of transplanted patients (n=19; 48.7% vs n=1097; 
79.7%) significantly lower compared to the ERA-EDTA 2010 annual report.
Discussion 
This study presents an overview of the epidemiology and etiology of 
ESRD and RRT in Slovak children, focusing on changes observed in the 
period 2003-2009 compared to historical data and data on the European 
perspective. The median annual incidence rate of RRT in Slovak children 
under age 15 years in this period was 6.6 pmarp. These rates were somewhat 
higher than that in the preceding study on Slovak children in 2002 (Zvara 
et al. 1978), but without statistical significance. Data on the incidence of 
RRT regarding the first Slovak study from 1978 are not available, but it 
seems likely that the number of patients initiating RRT was lower as a 
consequence of the unavailability of dialysis and transplantation in the 
past. Compared with neighboring countries and with the European 
average, no significant differences in incidence rates were found. 
Explanations for these similarities are the similar demographic structure 
but also the seemingly comparable availability of dialysis. An increase 
in the incidence rates of RRT can thus be expected, as the European RRT 
incidence is currently rising (van der Heijden 2004, Warady and Chadha 
2007, ESPN/ERA-EDTA Registry 2010).
On the basis of the available prevalence data (1.5 pmarp in 1977, 
18.6 pmarp in 2002, 24.1 pmarp in 2009), it could be assumed that the 
initially steep rise of RRT prevalence rates stabilized a couple of years 
after introducing dialysis and transplantation into the treatment regime 
of Slovak children. Later variations could easily be due to fluctuation 
by chance (18.6 pmarp in 2002, 27.0 pmarp in 2007, 24.1 pmarp in 2009). 
Regarding neighboring countries, prevalence rates were significantly 
higher in the neighboring Austria but not in other neighboring countries. 
Moreover, the average European prevalence rate was higher. The higher 
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prevalence in Austria and in some other mostly western European 
countries may be due to the combination of improved medical care for 
patients in earlier stages of CKD in combination with earlier treatment 
of ESRD, especially in younger ages where a low weight can also play a 
significant role for establishing dialysis (van der Heijden 2004, Warady 
and Chadha 2007).
The predominance of congenital and hereditary reasons as the 
main causes of ESRD in children has similarly been found in a study 
on neighboring Poland (Zurowska et al. 2006) and in many other 
previous studies on Europe (Ardissino et al. 2003, British Association 
for Paediatric Nephrology 2005, Lewis et al. 2010) and other parts of the 
world (U.S.Renal Data System 2005, North American Pediatric Renal 
Trials and Collaborative Studies 2007). A study of the British Association 
of Paediatric Nephrology published in December 2009, the most recent 
European study, reported a higher proportion of CAKUT (50.0%) and 
congenital nephrosis (9.3%) (Lewis et al. 2005). A Dutch study on the 
period 1987-2001 reported a relatively very high proportion of urethral 
valves (14.3%) as the reason for ESRD, which contrasts with the Slovak 
results, in which there was zero contribution of urethral valves among 
RRT patients. Environmental, ethnic and other differences might explain 
the different occurrence of primary renal diseases in Europe compared to 
our findings (Warady and Chadha 2007).
Strengths and limitations
An important strength of our study is that we obtained data on the entire 
country using a rigorous data collection. A limitation is the relatively small 
number of children, which limits the potential for subgroup analyses. 
Conclusion
A slightly positive trend both for incidence and prevalence rates of 
pediatric RRT patients has been present in Slovakia during the past 
decade, although no significant difference compared to the last study 
(2002) was found. The comparison with the neighboring countries and 
with the European average shows no significant differences in incidence. 
The prevalence does not significantly differ from that of most of its 
neighbors but is significantly lower compared with neighboring Austria 
and some other (mostly western) European countries as well as the 
European average. 
A central national registry for children on RRT should be established, 
not only to facilitate epidemiological analyses and longitudinal studies 
but also as a first step toward monitoring and improving the quality of 
health care and quality of life of Slovak children.  
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Abstract
Objectives 
Ethnic differences in the occurrence of end-stage renal disease (ESRD) 
are reported on various populations across of the world, but evidence on 
Roma is lacking. The aim of this study was to explore the relative risk (RR) 
of ESRD for Roma who constitute a major minority in Slovakia. 
Methods 
Patients treated by means of hemodialysis during 2005-2008 were 
questioned for their ethnicity. Rates of ESRD among Roma and non-Roma 
based on hemodialyis data were calculated as well as the RR of Roma for 
ESRD. The latter was repeated after standardization for differences in age 
of both populations.
Results 
Roma represented 11.6% of all hemodialyzed patients. The RR of ESRD 
for Roma was 1.34, compared to the majority population. After age 
standardization, the RR for Roma was 2.85.
Conclusion 
This study shows that the risk for ESRD is significantly higher for Roma 
than for non-Roma. A genetic propensity of Roma to renal failure might 
partially explain the higher risk. Moreover, a poorer control of risk factors 
for ESRD in Slovak Roma contributes to the increased risk.




Ethnic differences in the occurrence of end-stage renal disease (ESRD) 
have been shown for many parts of the world. The incidence of ESRD 
in African Americans is 2-3 times higher compared to the Caucasian 
Americans (U.S. Renal Data System 2009). Similarly, the incidence of 
ESRD in Australian Aborigines is significantly higher compared to non-
indigenous inhabitants, the age-adjusted rate reaches 20-fold in some age 
categories (McDonald et al. 2010). Published estimates of ESRD incidence 
among inhabitants of India range from 150 to 232 people per million 
population (pmp) per year, compared to 76-193 people pmp per year in 
European countries (Agarwal and Srivastava 2009, ERA-EDTA Registry 
2010, Modi and Jha 2006, Prabahar et al. 2008). Indo-Asian immigrants 
in the United Kingdom (UK) have approximately 3-5 times higher 
incidence rates of ESRD compared to the majority population in the UK 
(Lightstone 2003). Genetic factors have been found to be contributing to 
the deterioration of renal functions in the Indian population, and may 
partially explain this higher incidence (Tripathi et al. 2008).
In Slovakia as well as in several other European countries, Roma 
constitute a major ethnic minority. They may have come to Europe from 
the Indian subcontinent (Zeman et al. 2003). Reliable estimates of the 
size of the Roma population in Slovakia are difficult to obtain; according 
to the Slovak national census in 2001 about 90 000 Roma were living in 
Slovakia, 1.7% of the population. The Institute of Informatics and Statistics 
of the Slovak Republic (Infostat) provides more reliable estimates of 
approximately 380 000 Roma in 2001, representing about 7% of the Slovak 
population (Vano 2002). Other sources come to higher estimates, ranging 
from 8 to 12% (Koupilova et al. 2001, Kröhnert et al. 2008).
There is lack of evidence on the occurrence of ESRD among Roma. 
This could be hypothesized to be high, considering the high occurrence of 
ESRD in India where Roma may have come from (Agarwal and Srivastava 
2009, Modi and Jha 2006, Sakhuja and Sud 2003) and among the Indian 
immigrants in Europe (Lightstone 2003). Therefore, our aim was to 
compare the occurrence of ESRD between Roma and non-Roma and to 
calculate the relative risk (RR) of Roma for ESRD by age groups.
Methods
Patients
The total sample consisted of 1,407 ESRD patients treated by means of 
hemodialysis in Slovakia in years 2005-2008, representing 32.5% of all 
dialyzed patients on average. This comprised 1,361 adult patients treated 
in one of the 18 Fresenius dialysis units all over Slovakia and all pediatric 
patients up to 19 years of age (n=39) treated in one of the four tertiary 
centers for pediatric nephrology in the same period. 
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Data and data collection 
Data on adults obtained from lists of all patients dialyzed at all centers 
participating in the study with patients’ details. Data on children were 
collected using questionnaires sent by e-mail to the heads of pediatric 
dialysis and transplantation centers in Slovakia. For each patient data on 
age, gender, primary renal disease and date of the beginning and end 
of dialysis (if applicable) were retrieved from the medical records. The 
primary renal diseases were recorded as diagnosed by every centre in 
Slovakia. Ethnicity was measured based on patients’ self- identification 
and the assessment of the nephrologist. In case of a mismatch the opinion 
of the third person (the head-nurse) was decisive.
Population data on the majority population (2005-2008) were 
obtained from the Statistical Office of the Slovak republic (2011). 
Population data on Roma were obtained from Infostat and represent a 
middle prognostic variant of the Roma population development  (Vano 
2002). The estimate of the number and age-sex structure of Roma living in 
the Slovak Republic as of 31 December 2001 was based on data from the 
period between the censuses in 1980 and 2001, i.e., an estimation algorithm 
was constructed based on the 1980 census and then calibrated using the 
1991 and 2001 censuses. Using this calibrated algorithm, numbers were 
estimated to forecast the development of the Roma population in the 
Slovak Republic to the year 2025 (Vano 2002).
Statistical analyses
Relative risks of ESRD for Roma compared to the remainder of the Slovak 
population were estimated for 15-years age categories (0-14, 15-29, 30-
44, 45-59, 60-74, 75+).  First, we estimated the relative risks of ESRD for 
Roma compared to the remainder of the Slovak population per 15-year 
age category (0-14, 15-29, 30-44, 45-59, 60-74, 75+). Next, we estimated 
the summary relative risks across all ages using direct standardisation 
to account for the large differences in age-distribution between Roma 
and the remainder of the Slovak population. In order to do this, we 
computed the expected numbers of ESRD cases among Roma per 5-year 
age category as the product of the number of Roma in the population in 
that age category, and the rate  of ESRD in the majority population in 
that age category. We then estimated a standardized ratio for Roma as the 
observed number of ESRD, summarized across all age categories, divided 
by the expected number of cases of ESRD across all age categories. Finally, 
Poisson regression analyses were used to model the risks for ESRD 
because of the number of primary renal diseases. The differences were 




Data concerned 1,407 patients (778 males, 629 females); 146 of them were 
identified as Roma, 3 patients were of other non-Slovak ethnicity. The 
share of Roma among hemodialyzed represented 11.6%. 
Roma patients with incident ESRD were on average younger than 
other patients. The mean age of incident Roma at the time of hemodialysis 
initiation was 52.1±14.7. Compared to the mean age of the incident majority 
patients 61.6±14.7 the age of the Roma patients at the time of hemodialysis 
initiation was significantly lower.
The RR of ESRD for Roma was 1.34 times higher compared to the 
majority population. After standardization to the age distribution of the 
majority population, the overall RR was 2.85 (95% confidence interval 
2.56-3.17) range 1.82-3.42 for RR as standardized in the various 15-year 
age-categories (Table 4.1) (Rothman et al. 2008).




Table 4.1 Estimated relative risk (RR) of end-stage renal disease (ESRD) in Roma compared to the majority Slovak 
population 
* average per 2005-2008 period 
 
 










RR for ESRD (standardized) 
[95% confidence interval] 
0-14 873 572 21 129 278 5 1.82 [1.18-2.82] 
15-29 1 308 243 41 128 983 10 2.77 [2.03-3.79] 
30-44 1 192 744 96 87 591 20 3.42 [2.75-4.26] 
45-59 1 132 677 240 49 574 29 3.14 [2.61-3.76] 
60-74 615 426 304 13 938 16 2.47 [1.94-3.16] 
75+ 273 140 109 3 053 3 2.38 [1.35-4.20] 
Total 5 395 802 810 412 416 83 2.85 [2.56-3.17] 
* average per 2005-2008 period
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Poisson regression showed that diabetic nephropathy occurred more 
frequently as cause of ESRD among Roma than among non-Roma 
(p=0.033) (Table 4.2).
Table 4.2 Proportions of primary renal diseases (PRD) of dialyzed patients in Roma and non-Roma
39 
 
Table 4.2 Proportions of primary renal diseases (PRD) of dialyzed patients in Roma and non-Roma 
PRD Majority population* Roma population* 
 n (%) n (%) 
Diabetic nephropathy 218 (26.9)  30 (36.1)  
Interstitial nephritis 185 (22.8)  16 (19.3) 
Glomerulonephritis  106 (13.1) 10 (12.0) 
Hypertensive kidney disease 57 (7.0) 6 (7.2) 
PKD  47 (5.8)  3 (3.6) 
CAKUT 28 (3.5) 3 (3.6) 
Other 79 (9.8)  8  (9.6) 
Unknown or unclassified 90 (11.1) 7 (8.4) 
Total 810 (100.0) 83 (100.0) 
PKD: polycystic kidney disease, CAKUT: congenital anomaly of kidneys and urinary tract, * average per 2005-2008 period 
PKD: polycystic kidney disease, CAKUT: congenital anomaly of kidneys and urinary tract, * 
average per 2005-2008 period
Discussion 
This is the first study that shows an overview of ethnic differences in 
Slovak hemodialyzed patients. The results show that the RR of ESRD for 
Roma is 1.34 times higher compared to the majority population. It is even 
higher 2.85 after taking into account the much younger mean age of Roma. 
An explanation for the higher RR of Roma may be a genetic propensity 
of Roma to renal failure, possibly associated with a background from the 
Indian subcontinent (Tripathi et al. 2008). Roma also share with people 
from the Indian subcontinent a high occurrence of diabetic nephropathy. 
A significantly higher occurrence of diabetic nephropathy was found 
in Slovak hemodialyzed Roma, which may contribute to the higher RR 
for ESRD among Roma. At least a part of the increased risk of ERSD in 
the Roma population may be related to a delayed diagnosis and a lack 
of control of the main ESRD risk factors, such as hypertension, diabetes 
mellitus and smoking.  Another contributing factor may be the low birth-
weight that occurs significantly more frequently among Roma newborns 
and, according to Brenner’s and Barker’s theory, might also contribute to 
the higher occurrence of CKD and ESRD in Roma (Barker and Martyn 
1992, Bobak et al. 2005, Brenner and Chertow 1994, Rimarova et al. 2004). 
A fourth  factor that contributes to a higher risk of ESRD among Roma 
may be consanguinity. Finally, a deprived socioeconomic position or even 
marginalization of the Roma community may contribute to the burden of 
ESRD in this particular population (Hurtado and Johnson 2005).
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Strengths and limitations
Strengths of our study are that it concerns national data on a several years 
regarding on a country with a large Roma minority. Limitations are that 
we did not have a full national coverage, but we could estimate the share 
of the population covered by our study very accurately and this share has 
been shown to be unselected (Statistical Office of Slovak Republic 2011). A 
second limitation might be that we estimated the size and age distribution 
of the Roma population. However, we used by far the best estimate as 
available. Moreover, even if the share of Roma in the total population 
would be twice as high, rates among Roma are still higher than among 
the majority population showing that this is very unlikely to affect our 
findings. A limitation might be that the number of ESRD patients was 
assessed based on the number of RRT patients. As ESRD is fatal, without 
RRT it seems unlikely that missing ESRD cases might have biased our 
findings. However, a higher lethality of ESRD among Roma might have 
occurred. In that case, our figures are an underestimation of the increase 
in risk among Roma.
Implications for practice and further research
Policies aimed at improving minority health status and access to healthcare 
in Roma are essential to reduce inequalities in health between the minority 
and majority populations (Nielsen and Krasnik 2010, Dostal et al. 2010). 
Based on our results, the population’s attributable risk for ESRD due 
to Roma having ESRD was estimated as 37.4%, i.e. 37.4% of all cases of 
ESRD in Slovak children is due to the excess risk in Roma. This causes 
a significant burden of disease. It can also be considered significant in 
terms of costs for RRT, as annual costs for dialysis per pediatric patient are 
approximately 20,000 euro in Slovakia. Physicians should be more aware 
of the higher risk of Roma for earlier reaching of ESRD and focus more 
on modifiable risk factors in order to postpone its onset, thus decreasing 
significantly both this burden of disease and the associated costs. For 
example screening for hypertension, diabetes mellitus and hematuria in 
family members of Roma with progressive hereditary nephritis might be 
done to decrease the overall number of patients who need RRT. Moreover, 
general measures to increase the access to health care for Roma may also 
lead to a more timely treatment of risk factors for ESRD.
Conclusion
The RR of ESRD for Roma was 1.34 times higher compared to the majority 
population. After standardization, the RR was 2.85 (Table 1). The genetic 
propensity of Roma to renal failure may explain a part of this higher 
risk, as well as a poorer control of risk factors for ESRD among them. A 
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significantly higher occurrence of diabetic nephropathy in Slovak Roma 
contributes to the increased risk.
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Chapter 5 
Kidney diseases in Roma and non-Roma 
children from eastern Slovakia: are 
Roma children at risk?
Gabriel Kolvek, Ludmila Podracka, Jaroslav Rosenberger, Roy E. Stewart, 
Jitse P. van Dijk, Sijmen A. Reijneveld




To compare the occurrence of primary renal diseases (PRD) in Roma and 
non-Roma children.
Methods 
Data on all outpatients (n=921) from a tertiary pediatric nephrology centre 
(<19 years) in eastern Slovakia were collected. We assessed early signs and 
symptoms and PRD for Roma and non-Roma children.
Results 
The proportion of Roma among patients was relatively small regarding 
early signs like proteinuria but large regarding PRD with gross clinically 
apparent symptoms (e.g. Alport syndrome, p<0.01 and systemic lupus 
erythematosus, p<0.05). 
Conclusions 
The overall proportion of Roma children in outpatients with kidney 
problems is smaller than the estimated proportion of Roma in all children 
in Slovakia, in particular for early signs, but not for major renal diseases.
Keywords: children, ethnicity, primary renal disease, Roma
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Introduction 
Ethnic differences in the occurrence of primary renal diseases (PRD) among 
children have been shown for different parts of the world (NAPRTCS 
2008, Lewis et al. 2010). In the British national registry, the proportion of 
patients from ethnic minority groups varies widely between categories, 
with congenital nephrosis being the one with the largest proportion of 
ethnic minority patients (Lewis et al. 2010). Similarly, a large proportion of 
minority patients has been found in the North American Pediatric Renal 
Trials and Collaborative Studies for focal segmental glomerulosclerosis 
(NAPRTCS 2008). Ethnic minorities are reported to be overrepresented 
among end-stage renal disease (ESRD) patients while at the same time 
they are underrepresented in earlier stages of chronic kidney disease 
(Tarver-Carr et al. 2002, Gao et al. 2007).
In several European countries Roma constitute a major ethnic 
minority. Reliable estimates of the size of the Roma population are 
difficult to obtain, of the age-structure of this population even more so. 
The Institute of Informatics and Statistics of the Slovak Republic (Infostat) 
provided a reliable estimate that Roma make up approximately 7% of the 
whole Slovak population, and 13.3% of inhabitants under the age of 20 
years (Vano 2002). Recent estimates on the whole Slovak population are 
similar (7.5%) (Ministry of the Interior of the Slovak Republic 2013).
Evidence is lacking on the degree to which Roma children are 
referred to nephrological care, overall and regarding specific diagnoses. 
On the one hand, their proportion may be larger in this type of care than in 
the general population, as the proportion of Roma among ESRD patients 
has been shown to be larger than expected on the basis of their proportion 
in the general population (Kolvek et al. 2012). On the other hand, factors 
like a lack of knowledge and a lack of means may hamper their access 
to specialized care, which would lead to underrepresentation (Erasmus 
MC-University Medical Centre Rotterdam Rotterdam 2007, Jarcuska et al. 
2013).
The aim of this study was firstly to compare the proportion of Roma 
and non-Roma children in a tertiary pediatric nephrology clinic with that 
in the general population, and secondly to compare the proportion of 
Roma and non-Roma regarding early signs of PRD and specific PRD.
Methods
Patients
The sample consisted of the records of 921 patients under the age of 19 
years (as of June 15, 2010), which represented the active records of the 
outpatient clinic in the tertiary pediatric nephrology centre in Children’s 
University Hospital, Kosice, as of that date. 
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Data and data collection 
Clinical variables were derived from the medical files. For each patient data 
on age, gender, and PRD or the presenting symptoms of the nephropathy 
were retrieved from the medical records. Ethnicity was assessed based on 
patients’ self-identification and the assessment of the nephrologist. In the 
case of a mismatch the opinion of a third person (the nurse) was decisive. 
Data on the proportion of Roma and non-Roma children in the catchment 
area were obtained from the Infostat (Vano 2002). Data on patients <19 
years of age were compared with the number of inhabitants <20 years of 
age due to the unavailability of ethnicity data per birth year in individual 
years.
Statistical analyses
First, we calculated the ratio of observed versus expected numbers of Roma 
patients. Next, we tested the statistical significance of the differences using 
a z-statistic (Fleiss 1981). The differences were considered significant if  p 
was < 0.05. SPSS 20.0 and SAS 9.1 were used for the statistical analyses.
Results
Proportion of Roma and non-Roma children among patients 
The data comprised 921 patients (478 boys); 97 of them (51 boys) were 
identified as Roma. The mean age of patients at the time of data collection 
was 11.8±5.2 years (12.3±5.6 in Roma vs. 11.8±5.2 in non-Roma; p>0.05). 
The proportion of Roma children in all patients was 10.5%. This was 
smaller than the estimated proportion of Roma children in the general 
Slovak population (13.3%; p<0.05). 
Proportion of Roma and non-Roma children according to diseases and risk 
factors 
The proportion of Roma among patients was in particular significantly 
smaller (p<0.01) regarding early signs and risk factors like proteinuria 
and hypertension (Table 5.1). On the other hand, the proportion of 
Roma was larger than expected based on the proportion of Roma in 
the total population for diseases with obvious clinical signs, such as 
gross hematuria, generalized swelling, rash etc. Examples were Alport 
syndrome (p<0.01) and systemic lupus erythematosus (p<0.05).
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Discussion  
We compared ethnic differences in the proportion of Roma and non-
Roma children in specialized nephrological care in eastern Slovakia. 
We found that Roma were overall underrepresented in this care. The 
proportion of Roma was especially small in patients without obvious 
signs and symptoms, while the proportion of Roma was relatively large 
among patients with PRD presenting with obvious signs, such as gross 
hematuria or generalized swelling. 
The small overall proportion of Roma children among these patients 
contrasts with the relatively large proportion of Roma pediatric ESRD 
patients, as recently reported for the same population (Kolvek et al. 2012). 
An explanation for this contrast might be that Roma patients do not show 
up until after their kidney disease has progressed to ESRD and do not 
reach pediatric clinics with early signs and risk factors. This fits with our 
previous finding that among incident patients requiring dialysis, a rather 
large proportion of Roma had not been previously seen by a nephrologist 
(22%), whereas all non-Roma children had already been seen previously 
(Kolvek and Podracka 2012). One possible explanation is that Roma have 
poor access to specialized nephrology care, as compared with non-Roma, 
which may hold even more for children due to their dependency on 
parents. Lack of means, problems with transportation or discrimination 
have all been suggested as possible explanations (Babinska et al. 2013, 
Erasmus MC-University Medical Centre Rotterdam Rotterdam 2007, 
Jarcuska et al. 2013, Kolarcik et al. 2009, Sudzinova et al. 2013). Financial 
barriers to access are rather unlikely as primary as well as specialized care 
in Slovakia is fully covered by the compulsory insurance which is paid by 
social security when there is a lack of means. 
However, other barriers may occur. One reason could be the attitude 
of Roma toward their own health and to the health of their children. 
Studies comparing Roma with non-Roma have shown that Roma perceive 
the relationship between lifestyle and health much less as being strictly 
causal; the issue of health and disease is understood rather fatalistically 
(Petek et al. 2006, Van Cleemput et al. 2007). Evidence on the way Roma 
care for their children is completely lacking. A third and possibly crucial 
reason why Roma children show up only after obvious clinical symptoms 
have developed is a poor understanding of the disease, leading them not 
to respond to early signs.
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Table 5.1 Diagnoses in Roma and non-Roma patients, primary renal diseases (PRD) and other 
diagnoses: the proportion of Roma and non-Roma children per diagnosis and the ratios of the 
proportions of Roma in the diagnosis group and in the population; Slovakia 2010
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Table 5.1 Diagnoses in Roma and non-Roma patients, primary renal diseases (PRD) and other diagnoses: the 
proportion of Roma and non-Roma children per diagnosis and the ratios of the proportions of Roma in the 
diagnosis group and in the population; Slovakia 2010 
CAKUT: congenital anomalies of kidneys and urinary tract; HUS: hemolytic-uremic syndrome; MMC: meningomyelocele; PKD: 
polycystic kidney disease; SHP: Schönlein-Henoch purpura; SLE: systemic lupus erythematosus 
n.s. = not statistically significant 
*Observed share of Roma patients / Expected number based on their share in the population 
^Patients referred for hypertension, proteinuria, erythrocyturia, enuresis or a history of urinary tract infection, i.e. those in 
whom no certain PRD was confirmed 
 
Diagnosis Non-Roma patients Roma patients Observed/Expected* Sig. 
 n (%) n (%) % / % p 
Number of inhabitants <20 years All Non-Roma <20 All Roma <20   











Glomerulopathy 69 (74.2) 24 (25.8) 1.94 <0.01 
- Idiopathic nephrotic syndrome      58 (78.4)      16 (21.6) 1.62 n.s. 
- Other glomerulonephritis      11 (57.9)       8 (42.1) 3.17 <0.01 
Hereditary nephritis  7 (38.9) 11 (61.1) 4.59 <0.01 
- Alport syndrome       3 (21.4)      11 (78.6) 5.91 <0.01 
CAKUT (including MMC) 267 (88.7) 34 (11.3) 0.85 n.s. 
Vasculitis 32 (84.2) 6 (15.8) 1.19 n.s. 
- SLE       3 (50.0)        3 (50.0) 3.76 <0.05 
- SHP      29 (90.6)      3 (9.4) 0.71 n.s. 
HUS 13 (100.0) 0 (0.0) 0.00 n.s. 
Cystic disease 13 (81.2) 3 (18.8) 1.41 n.s. 
- PKD      10 (90.9)     1 (9.1) 0.68 n.s. 
- Juvenile nephronophtisis       5 (83.3)       1 (16.7) 1.26 n.s. 
Interstitial nephritis 10 (83.3) 2 (16.7) 1.26 n.s. 
Wilm’s tumor 9 (100.0) 0 (0.0) 0.00 n.s. 
Others or unknown 13 (86.7) 2 (13.3) 1.00 n.s. 
No PRD established  ^ 389 (96.1) 16 (3.9) 0.29 <0.01 
Total 824 (89.5) 97 (10.5) 0.79 <0.05 
CAKUT: congenital anomalies of kidneys and urinary tract; 
HUS: hemolytic-uremic syndrome; 
MMC: meningomyelocele; 
PKD: polycystic kidney disease; 
SHP: Schönlein-Henoch purpura; 
SLE: systemic lupus erythematosus
n.s. = not statistically significant
*Observed share of Roma patients / Expected number based on their share in the population
^Patients referred for hypertension, proteinuria, erythrocyturia, enuresis or a history of urinary 
tract infection, i.e. those in whom no certain PRD was confirmed
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On the other hand, this study shows that Roma children are 
overrepresented in certain PRD, particularly those which typically present 
with obvious signs and symptoms, such as gross hematuria, generalized 
swelling and typical rash. This may firstly be due to a poor response to 
early signs, which makes progress of the disease to ESRD more likely. A 
different genetic load may add to the explanation of the larger proportion 
of Roma among patients with Alport syndrome and SLE. A higher genetic 
risk of SLE has been described in other minorities as well, especially 
African-Americans (NAPRTCS 2008). A recent study showed similarly 
increased rates of chronic kidney disease among Roma adults compared 
with non-Roma adults as well (Rosenberger et al. 2014). Other diseases 
have been found to be overrepresented in Roma due to higher genetic risk 
(Bouwer et al. 2007, Gabrikova et al. 2013)
A strength of this study is that it presents a sample that covers a large 
region with a large Roma minority. The size of the sample can also be 
considered a strength. Our main limitation is that the information on the 
proportion of Roma in the population was based on estimates. However, 
we think that these estimates are rather valid. Moreover, differences are so 
pronounced that their statistical significance remains unaffected by likely 
inaccuracies in these estimates. 
Earlier diagnosis of kidney diseases in Roma children might be 
achieved by improving their access to specialized care. More evidence 
is needed on the process leading to poorer access, with a focus on the 
increased health literacy of Roma parents, the behavior of professionals, 
communication barriers and lack of means. This further research should 
focus in particular on segregated Roma settlements with the poorest 
living conditions and educational status. 
Conclusions
Roma are underrepresented in specialized care for children with kidney 
problems, which contrasts with their overrepresentation among ESRD 
patients. An explanation for this contrast might be that Roma patients 
do not find care until after their kidney disease has progressed to ESRD. 
The significantly smaller proportion of Roma among patients referred for 
symptoms found in this study supports this explanation.  Access of Roma 
children to specialized care thus requires utmost attention.
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Abstract
Background  
This study aims to assess the cumulative incidence of elevated albuminuria, 
hypertension and decreased estimated glomerular filtration rate (eGFR) 
to identify possible renal injury in children with SFK. 
Methods 
Forty-two children with SFK (23 boys; 27 congenital) were included in a 
prospective follow-up study. Blood pressure, albuminuria and eGFR were 
assessed repeatedly and the cumulative incidence rate of various forms of 
renal injury, overall and by type of etiology, were evaluated. Finally, renal 
injury-free survival was analyzed.
Results 
Mean follow-up was until age 11.3 years (SD 6.3 years). During follow-
up, 16 (38.1%) patients met the criteria for renal injury, defined as 
hypertension (10; 23.8%), severely increased albuminuria (3; 7.1%) and a 
significantly impaired eGFR (<60ml/min/1.73m2) (5; 11.9%) and/or use 
of antihypertensive or antiproteinuric medication (11; 26.2%). Children 
with CAKUT in SFK had a significantly higher incidence of renal injury. 
The median time to develop renal injury was 12.8 years.
Conclusion 
A substantial proportion of children with SFK develop renal injury 
during childhood, especially those with CAKUT in the SFK. Therefore, 
close follow-up of albuminuria, blood pressure and eGFR are warranted 
to identify chronic kidney disease in its early stages.




In 1988 Brenner et al. described their ground-breaking hyperfiltration 
hypothesis in rats with subtotal renal mass reduction (Brenner et al. 
1988; Hostetter et al. 1981), suggesting that a reduction in the number of 
functioning nephrons leads to haemodynamic changes in the residual 
glomeruli and ultimately results in glomerular sclerosis (Brenner 1985; 
Brenner and Mackenzie 1997). Several post-mortem studies as well 
as clinical observations of hypertensive patients also supported the 
hyperfiltration hypothesis in humans (Keller et al. 2003; Hoy et al. 2006; 
Hughson et al. 2006; Siomou et al. 2014). Nephron endowment at birth, 
which varies widely from 200,000 to more than 2,500,000 per kidney 
(Hoy et al. 1999; Hughson et al. 2003; Bertram et al. 2011), may thus be 
understood as a determining factor of kidney survival. Unfortunately, 
measures or even estimates of the nephron number in vivo are currently 
impossible.  
A solitary functioning kidney (SFK) is a unique model of renal-mass 
reduction; thus, consequences due to hyperfiltration may be expected. 
Paradoxically, living-kidney donors are frequently shown to have stable 
renal function over more than 25 years after nephrectomy (Hakim et 
al. 1984; Najarian et al. 1992; Goldfarb et al. 2001). In children with SFK 
controversies regarding renal function exist. Some studies support 
favorable outcomes, which is the opposite of what might be expected 
according to the Brenner hypothesis (Simon et al. 1982; Robitaille et al. 
1985), while others do not, both in children after nephrectomy (Argueso 
et al. 1992b; Abou Jaoude et al. 2011) and in children with congenital SFK 
(Argueso et al. 1992a). Follow-up studies are scarce. In 2009 Sanna-Cherchi 
et al. presented their renal survival analysis in patients born with one 
kidney, showing that 50% of these patients needed dialysis by the age of 
30 years old, a result which highlighted potential subclinical renal defects 
(Sanna-Cherchi et al. 2009). Recent findings of Westland et al. showed a 
median time to renal injury of 14.8 years (14.9 years for congenital SFK) 
(Westland et al. 2013b). Due to differences in sampling and design, 
however, these findings cannot be fully compared, and further evidence 
on this issue is lacking. 
Until the measurement of the number of nephrons in vivo is possible, 
only observational longitudinal follow-up studies may shed further light on 
the long-term prognosis for children with SFK. Our aim was to add to this 
evidence by studying Slovak children with SFK using a methodology that 
enables comparison with the already available evidence. KDIGO experts 
have recently published a consensus guideline defining ‘albuminuria’ as 
moderately (>30mg/24hours) or severely increased  (>300mg/24hours) 
and highlighted adverse consequences in people with albumin excretion 
and/or GFR <60ml/min/1.73m2 irrespective of the etiology or duration 
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of reduced kidney function (Kidney Disease: Improving Global Outcome 
2012). Thus, this study aims to assess the cumulative incidence of elevated 
albuminuria and hypertension and decreased GFR in SFK children in 
order to identify possible renal injury during childhood using a similar 
methodology as Westland et al. (Westland et al. 2013b).
Patients and methods
Patients
All children with SFK who were followed at a tertiary nephrology centre 
(Safarik University Hospital, Kosice, Slovakia) were included in this 
prospective follow-up study (N=47). SFK was defined as the unilateral 
absence of a (functioning) kidney at ultrasound, confirmed by renal 
scintigraphy. Children with an acquired SFK as a result of malignancy (n=5; 
Wilms’ tumor: 3, renal cell carcinoma: 1, neuroblastoma: 1) were excluded 
because of potential confounding effects due to the use of nephrotoxic 
chemotherapy. Thus, 42 patients were eligible for the analyses.
To identify potential differences between two groups of SFK, patients 
were divided into two categories: congenital SFK or acquired SFK. A 
congenital SFK can be due to unilateral agenesis/aplasia or a multicystic 
dysplasia. Children who underwent a unilateral nephrectomy were 
classified as those with acquired SFK. Indications for nephrectomy are 
shown in Table 1. To study the additional effect of congenital anomalies 
of kidneys and urinary tract (CAKUT), patients were also subdivided into 
two more categories: “CAKUT +” (i.e. CAKUT in SFK) and “CAKUT –” 
based on the presence or absence of CAKUT as diagnosed by ultrasound 
and a DMSA scan. Seven (58.3%) out of 12 patients had vesicouretheral 
reflux, 3 (25.0%) had dysplasia and 2 (16.7%) had hydronephrosis in the 
SFK.
Measurements
Blood pressure was measured by the auscultatory method with an 
appropriate cuff size. To minimize the effect of stress, the lowest of three 
measurements was used. Hypertension was defined as systolic and/or 
diastolic blood pressure ≥95th percentile, corrected for age, gender, and 
height (National High Blood Pressure Education Program Working Group 
on High Blood Pressure in Children and Adolescents 2004). Severely 
increased albuminuria was defined using the KDIGO terminology as 
urinary albumin excretion >300mg/24 hours in timed collected urine 
samples (24 hours) (Mogensen et al. 1995; Kidney Disease: Improving 
Global Outcome 2012). Estimated glomerular filtration rate (eGFR) was 
calculated using the original Schwartz formula (eGFR=k x height/serum 
creatinine) (Schwartz et al. 1976) as the Jaffe method was used for the 
measurement of creatinine. Thus a new recently published Schwartz 
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formula was not fitting suitably as it is recommended for enzymatic 
measurement of creatinine (Schwartz et al. 2009). A significantly impaired 
eGFR was defined as an eGFR <60ml/min/1.73m2 (chronic kidney 
disease stage 3-4). Renal injury was defined as persistent presence of any 
of the following: hypertension and/or severely increased albuminuria 
and/or a significantly impaired eGFR and/or use of antihypertensive or 
antiproteinuric medication (Westland et al. 2013b). Angiotensin converting 
enzyme inhibitors were indicated if hypertension was present as defined 
in the fourth report on the diagnosis, evaluation, and treatment of high 
blood pressure in children and adolescents (National High Blood Pressure 
Education Program Working Group on High Blood Pressure in Children 
and Adolescents 2004)  or if albuminuria reached severely increased level 
according to the KDIGO definition (Kidney Disease: Improving Global 
Outcome 2012).
Statistics
We first assessed the etiology of the cases of SFK and the background 
characteristics of the sample overall and by type of etiology (congenital vs. 
acquired). Second, we assessed the cumulative incidence rate of various 
forms of renal injury, overall and by type of etiology. Finally, we performed 
an analysis of renal injury-free survival, and the degree to which this was 
determined by type of etiology and CAKUT in SFK. Chi-square tests 
(categorical variables) were used to assess the statistical significance of 
the differences between groups. Statistical significance was set at a p-level 
of 0.05. SPSS 20.0, and SAS 9.2 was used for the statistical analyses.
Results
Patients 
The data concerned 42 patients (23 boys) with SFK, of whom 27 with a 
congenital SFK (64.3%); data regarding the etiology is presented in Table 
6.1. The SFK in our sample was identified mainly accidentally during an 
abdominal ultrasound while 10 (23.8%) patients were referred when they 
were already showing signs of renal injury. In 5 patients (11.9%) the SFK 
was identified by neonatal ultrasound. The mean age at last follow-up 
was 11.3 years (standard deviation, SD: 6.3 years). The difference in age 
between children with congenital and acquired SFK was not significant 
(11.1 vs. 11.6 years, p=0.65). CAKUT+ was present in 12 (28.6%) patients, 




Table 6.2 shows that 16 (38.1%) patients met the criteria for renal injury 
– defined as a persistent presence of hypertension and/or severely 
increased albuminuria and/or a significantly impaired glomerular 
filtration rate (<60ml/min/1.73m2) and/or the use of antihypertensive or 
antiproteinuric medication – at a median age of 11.0 years. The occurrence 
of renal injury was similar in the congenital and acquired SFK group (p = 
0.39; Table 2), but differed between the CAKUT+ and CAKUT– children 
(p < 0.01; Table 6.3). Hypertension, severely increased albuminuria 
and a significantly impaired eGFR were found during follow-up in 10 
(23.8%), 3 (7.1%) and 5 (11.9%) children, respectively. Antihypertensive 
or antiproteinuric medication was used by 11 (26.2%) patients. Mean 
eGFR at the last follow-up was 83.2 mL/min/1.73 m2 (SD 26.4 mL/
min/1.73 m2). None of the rates of these types of injury  differed with 
statistical significance by etiology, but the cumulative incidence rates of 
hypertension, severely increased albuminuria and  significantly impaired 
eGFR were significantly higher  in CAKUT+ versus CAKUT–; Tables 2 
and 3, respectively. In the entire cohort, 2 (4.8%) children developed end-
stage renal disease, at 6 and 16 years of age, both with significant CAKUT 
(namely dysplasia) in the SFK.
Table 6.1 Etiology of solitary functioning kidney (SFK)  
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 Table 6.1 Etiology of solitary functioning kidney (SFK)   
Type of SFK 
 
Number of patients (%) 
Congenital 27 (64.3) 
  Unilateral renal agenesis   15 (35.7) 
  Multicystic dysplastic kidney    12 (28.6) 
Acquired 15 (35.7) 
  Vesicoureteral reflux      2 (  4.7) 
  Ureteropelvic junction obstruction     6 (14.2) 
  Ureterovesical junction obstruction     2 (  4.7) 
  Renal artery stenosis     2 (  4.7) 
  Miscellaneous     3 (  7.1) 
Total 42 (100.0) 
 








Renal injury, total 16 (38.1) 9 (33.3) 7 (46.7)  0.39 
Hypertension 10 (23.8) 5 (18.5) 5 (33.3) 0.28 
Severely increased albuminuria   3 (  7.1) 2 (  7.4) 1 (  6.7) 0.93 
eGFR<60ml/min/1.73m2   5 (11.9) 3 (11.1) 2 (13.3) 0.83 
Anti-hypertensive/ -proteinuric 
medication 
11 (26.2) 6 (22.2) 5 (33.3) 0.43 
eGFR – estimated glomerular filtration rate. 
Percentages per type add up to more than the percentage under total as children may have more types of injury simultaneously 








Renal injury, total 16 (38.1) 10 (83.3) 6 (20.0) <0.01 
Hypertension 10 (19.0)   5 (41.7) 5 (16.7) 0.14 
Severely increased albuminuria   3 (  7.1)   3 (25.0) 0 (  0.0) <0.01 
eGFR<60ml/min/1.73m2   5 (11.9)   5 (41.7) 0 (  0.0) <0.01 
Anti-hypertensive/ -proteinuric 
medication 
11 (26.2)   7 (58.3) 4 (13.3) <0.05 
eGFR – estimated glomerular filtration rate; CAKUT – congenital anomaly of kidney and/or urinary tract. 
Percentages per type add up to more than the percentage under total as children may have more types of injury simultaneously 
 
 
Table 6.2 Cumulative incidence rate of renal injury, total and by type, in solitary functioning 
kidney (SFK) patients 
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 Table 6.1 Etiology of solitary functioning kidney (SFK)   
Type of SFK 
 
Number of patients (%) 
Congenital 27 (64.3) 
  Unilateral renal agenesis   15 (35.7) 
  Multicystic dysplastic kidney    12 (28.6) 
Acquired 15 (35.7) 
  Vesicoureteral reflux      2 (  4.7) 
  Ureteropelvic junction obstruction     6 (14.2) 
  Ureterovesical junction obstruction     2 (  4.7) 
  Renal artery stenosis     2 (  4.7) 
  Miscellaneous     3 (  7.1) 
Total 42 (100.0) 
 








Renal injury, total 16 (38.1) 9 (33.3) 7 (46.7)  0.39 
Hypertension 10 (23.8) 5 (18.5) 5 (33.3) 0.28 
Severely increased albuminuria   3 (  7.1) 2 (  7.4) 1 (  6.7) 0.93 
eGFR<60ml/min/1.73m2   5 (11.9) 3 (11.1) 2 (13.3) 0.83 
Anti-hypertensive/ -proteinuric 
medication 
11 (26.2) 6 (22.2) 5 (33.3) 0.43 
eGFR – estimated glomerular filtration rate. 
Percentages per type add up to more than the percentage under total as children may have more types of injury simultaneously 








Renal injury, total 16 (38.1) 10 (83.3) 6 (20.0) <0.01 
Hypertension 10 (19.0)   5 (41.7) 5 (16.7) 0.14 
Severely increased albuminuria   3 (  7.1)   3 (25.0) 0 (  0.0) <0.01 
eGFR<60ml/min/1.73m2   5 (11.9)   5 (41.7) 0 (  0.0) <0.01 
Anti-hypertensive/ -proteinuric 
medication 
11 (26.2)   7 (58.3) 4 (13.3) <0.05 
eGFR – estimated glomerular filtration rate; CAKUT – congenital anomaly of kidney and/or urinary tract. 
Percentages per type add up to more than the percentage under total as children may have more types of injury simultaneously 
 
 
eGFR – estimated glomerular filtration rate.
Percentages per type add up to more than the percentage under total as children may have more 
types of injury simultaneously
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Table 6.3 Cumulative incidence rate of renal injury, total and by type, in solitary functioning 
kidney (SFK) patients 
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 Table 6.1 Etiology of solitary functioning kidney (SFK)   
Type of SFK 
 
Number of patients (%) 
Congenital 27 (64.3) 
  Unilateral renal agenesis   15 (35.7) 
  Multicystic dysplastic kidney    12 (28.6) 
Acquired 15 (35.7) 
  Vesicoureteral reflux      2 (  4.7) 
  Ureteropelvic junction obstruction     6 (14.2) 
  Ureterovesical junction obstruction     2 (  4.7) 
  Renal artery stenosis     2 (  4.7) 
  Miscellaneous     3 (  7.1) 
Total 42 (100.0) 
 








Renal injury, total 16 (38.1) 9 (33.3) 7 (46.7)  0.39 
Hypertension 10 (23.8) 5 (18.5) 5 (33.3) 0.28 
Severely increased albuminuria   3 (  7.1) 2 (  7.4) 1 (  6.7) 0.93 
eGFR<60ml/min/1.73m2   5 (11.9) 3 (11.1) 2 (13.3) 0.83 
Anti-hypertensive/ -proteinuric 
medication 
11 (26.2) 6 (22.2) 5 (33.3) 0.43 
eGFR – estimated glomerular filtration rate. 
Percentages per type add up to more than the percentage under total as children may have more types of injury simultaneously 








Renal injury, total 16 (38.1) 10 (83.3) 6 (20.0) <0.01 
Hypertension 10 (19.0)   5 (41.7) 5 (16.7) 0.14 
Severely increased albuminuria   3 (  7.1)   3 (25.0) 0 (  0.0) <0.01 
eGFR<60ml/min/1.73m2   5 (11.9)   5 (41.7) 0 (  0.0) <0.01 
Anti-hypertensive/ -proteinuric 
medication 
11 (26.2)   7 (58.3) 4 (13.3) <0.05 
eGFR – estimated glomerular filtration rate; CAKUT – congenital anomaly of kidney and/or urinary tract. 
Percentages per type add up to more than the percentage under total as children may have more types of injury simultaneously 
 
 
eGFR – estimated glomerular filtration rate; CAKUT – congenital anomaly of kidney and/or 
urinary tract.
Percentages per type add up to more than the percentage under total as children may have more 
types of injury simultaneously
Kaplan-Meier analysis showed a median time to develop renal injury 
of 12.8 years. The proportion that remained free from renal injury at the 
end of 10 and 15 years was 70.8% and 43.5%, respectively (Figure 6.1). For 
the congenital SFK group assessed separately, the median time to develop 
renal injury was 13.3 years (p=0.91; congenital versus acquired). While the 
median time to develop renal injury was similar between the types of SFK 
(p=0.91), CAKUT+ patients had a borderline significant shorter median 
time to develop renal injury than did CAKUT- patients (19.0 years vs. 10.6 
years p=0.06)
Figure 6.1 Renal injury-free survival in children with a solitary functioning kidney
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This study demonstrates that a substantial proportion of children (38.1%) 
with SFK developed renal injury at the median age of 11.0 years. The 
estimated GFR decreased below 60ml/min/1.73m2 in 11.9% of patients, 
and 4.8% of the patients from our cohort reached end-stage renal disease 
during childhood. 
Our findings are in line with a recent study by Westland et al., 
who showed that in a large Dutch sample of 407 children 37% of SFK 
patients developed renal injury at a mean age of 6.4 (SD 5.9) years 
(Westland et al. 2013b). Our study is showing a similar proportion (38.1%) 
at a higher median age using more strict inclusion criteria (severely 
increased albuminuria). We identified renal injury in both the congenital 
and acquired SFK group. In contrast, Jaoude et al. found a significant 
difference favoring congenital SFK, which they interpreted as indicating 
a better functional adaptation in that etiological category (Abou Jaoude et 
al. 2010). Furthermore, a significant influence of CAKUT on renal injury 
prognosis was found even in our small sample in line with Westland’s et 
al. findings.
Two children in our cohort (4.8%) developed ESRD at the age of 6 
and 16 years which both had significant CAKUT (namely dysplasia) in the 
remaining kidney. Interestingly, Sanna-Cherchi et al. found that at a higher 
age, i.e. 30 years, half of children with congenital SFK had developed ESRD 
(Sanna-Cherchi et al. 2009). They explained their findings by subclinical 
defects in the SFK as well as by selection bias. A direct comparison with 
our sample is not possible due to our shorter follow-up period, but a clear 
tendency of increasing renal injury with age is visible. Thus our study is 
suitably filling the gap between young patient’s in Westland’s sample and 
significantly older patients in the sample of Sanna-Cherchi et al. 
During the past decades an increasing number of studies have 
supported the excellent outcomes of adult kidney donors (Hakim et al. 
1984; Najarian et al. 1992; Saran et al. 1997; Goldfarb et al. 2001). These 
are nowadays frequently cited as an argument for the good outcome of 
SFK patients in general. However, in our opinion studies on living-kidney 
donors cannot be compared with nephrectomised children because 
of several differences. First, hyperfiltration likely has a more serious 
impact if the nephrectomy is performed during childhood (Celsi et al. 
1986; Okuda et al. 1987; Argueso et al. 1992b). Second, life expectancy in 
children is more likely to exceed the periods of follow-up in the studies so 
far conducted. Thus, changes could possibly develop later, after 30 years, 
as proposed by Brenner and Mackenzie and recently by Siomou et al. 
(Brenner and Mackenzie 1997; Siomou et al. 2014). Third, the selection of 
apparently healthy donors may in fact imply the selection of patients with 
an above-average number of nephrons (Chevalier 2009).
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It is questionable whether findings on patients from mostly western 
countries allow direct comparison with the Slovak population. In this 
context Czech children may be the best fit. In 1991 Janda et al. reported 
on 40 patients with SFK (23 with agenesis, at a mean age of 11.9, SD 4.3; 
and 17 after nephrectomy with a mean age of 7.8, SD 3.9) in three-quarters 
of whom microalbuminuria was present. No child suffered from renal 
insufficiency during follow-up (Janda et al. 1991). In 2006 Seeman et al. 
reported good outcomes regarding a subgroup of patients with unilateral 
renal agenesis and no evidence of scars. When children of a comparable 
age with concomitant anomaly in SFK were tested, however, signs of injury 
were confirmed (Seeman et al. 2006). Unfortunately, Seeman’s study was 
cross-sectional at a median age of 10.0 years, which hampers inferences 
on further prognosis. As shown by the ItalKid registry, the probability 
of kidney survival sharply declines during puberty, and the same effect 
might be expected in children with SFK; this tendency is also visible in 
our data, as presented in Figure 6.1.
Strengths and limitations 
The strength of our study is that data on continued follow-up in a tertiary 
nephrology centre is presented. Albuminuria, a sensitive marker of kidney 
injury was prospectively followed what has been only rarely done so far 
in SFK patients. The main limitation is the limited number of patients 
included, which limited the power of our study. Second, our cohort for a 
significant part represents children with SFK who were referred because 
they showed symptoms (23.8%), therefore, our findings may overestimate 
the effects of SFK due to an overrepresentation of poorly faring children. 
A full community study might solve this issue but would obviously be 
very expensive due to the rare nature of SFK in children.
Implications
Our results support the need for a close follow-up of SFK patients, 
especially those with CAKUT in the SFK, as suggested by Corbani and 
Westland and many others (Corbani et al. 2011; Westland et al. 2013b; 
Shirzai et al. 2014), since at least a portion of these patients have an 
unfavorable prognosis and should be monitored more closely. As the 
accuracy of the creatinine-based equations is limited when GFR decreases, 
follow-up using a combined serum cystatin C/creatinine-based equation 
is recommended, if available (Wasilewska et al. 2006; Westland et al. 
2013a). Investigation of SFK in deceased individuals is advised in order to 
allow a retrospective classification of SFK patients into groups according 
to the number of nephrons per kidney. 
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Conclusion
A substantial proportion of children with SFK develop renal injury 
during childhood, especially those with CAKUT in the SFK. A close 
follow-up and regular monitoring of albuminuria, blood pressure and 
eGFR seems warranted to identify poorly faring children early and to 
postpone the progression of chronic kidney disease  by antihypertensive 
or antiproteinuric medication.
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Left ventricular hypertrophy in children 
and adolescents before and after 
kidney transplantation
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Left ventricular hypertrophy (LVH) is associated with premature death in 
children with chronic kidney disease (CKD). We studied its change over 
time, related to successful kidney transplantation (KTx) and assessed 
whether clinical variables were associated with left ventricular mass 
index (LVMI).
Methods 
We obtained records of all children and adolescents who were followed-
up at the tertiary nephrology center for children at the Children’s 
University Hospital in Kosice, Slovakia, during 2008-2014, had completed 
echocardiographic studies while on chronic dialysis and had undergone 
a successful KTx, n=25. We assessed the longitudinally recorded left 
ventricular mass index (LVMI) and presence/absence of LVH, and risk 
factors for LVH.
Results 
The average prevalence of LVH was 23.5% while on dialysis, and 29.4% 
after KTx (p=0.06). Pre-post changes per patient were relatively big. 
Uncontrolled systolic hypertension was significantly related with LVMI 
(p=0.03).  
Conclusion 
LVH is common after pediatric KTx and the reversibility of already 
present LVH seems to be rather problematic. Significant changes of LVMI 
on the individual level suggest that modification is feasible with thorough 
control of (systolic) hypertension and of other risk factors. 




Pediatric end-stage renal disease (ESRD) patients nowadays mostly 
survive until adulthood and beyond, but this is associated with additional 
morbidity too. Transplantation, as an ideal renal replacement therapy 
option, may be glorified for this dramatic improvement of the long-
term outcome. However, overall mortality remains high. Upon reaching 
adulthood, dialysis patients live 40-50 years less, and transplant patients 
20-25 years less than an age- and race-matched population (U.S. Renal 
Data System 2011). According to these data from the United States 22-
32% of this mortality excess may be explained by cardiovascular disease 
(U.S. Renal Data System 2011). Studies from other countries similarly 
showed that 40%-50% of all deaths among dialysis and transplantation 
patients can be attributed to cardiovascular or cerebrovascular causes (Oh 
et al. 2002; Schwartz et al. 2009). Uremic cardiomyopathy, stiffening of the 
vessels due to calcifications and premature atherosclerosis all contribute 
to this excessively increased cardiovascular risk. 
Left ventricular hypertrophy (LVH) is nowadays considered to be an 
early marker of cardiomyopathy in patients with chronic kidney disease 
(CKD) (Mitsnefes 2012). By the time maintenance dialysis is instituted, 
69 to 89% of the pediatric patients have evidence of LVH (Johnstone et 
al. 1996; Mitsnefes et al. 2001; Mitsnefes et al. 2003; Mitsnefes et al. 2006; 
Furth et al. 2011). To a certain extent the differences in prevalence of LVH 
among studies can be explained by the way how LVH is assessed (Foster 
et al. 2008; Khoury et al. 2009). Some studies suggest improvement after 
kidney transplantation (KTx) while others do not (Mitsnefes et al. 2001; 
Becker-Cohen et al. 2008). 
Intraindividual changes of the left ventricular mass index (LVMI) 
over time may be influenced by several factors. Some studies suggested an 
impact of changes in blood pressure (BP) (Matteucci et al. 1999; Mitsnefes 
et al. 2001; Kitzmueller et al. 2004; Becker-Cohen et al. 2006; Bullington et 
al. 2006; Becker-Cohen et al. 2008). In contrast, other studies did not find 
an association between BP and left ventricular mass (LVM) in children 
and suggested other contributing factors like body mass index (BMI), 
hemoglobin level, or the influence of medication (El-Husseini et al. 2004; 
Mitsnefes et al. 2004). Our center has added to this evidence previously 
(Hedvig et al. 2010). The aim of the current study was to describe changes 
in LVH in children and adolescents with ESRD over time, related to the 
moment of successful KTx and to assess whether clinical variables are 




We obtained records of all children and adolescents followed-up at the 
tertiary nephrology center for children at the Children’s University 
Hospital in Kosice, Slovakia during 2008-2014. Patients who had previously 
completed echocardiographic studies while on chronic dialysis and had 
already undergone a successful KTx were eligible for analysis (n=25). Two 
patients were excluded because of congenital heart defect, leading to a 
final sample of 23 children. To study the influence of KTx on LVH at the 
individual level we followed LVMI over time and compared patients with 
available measurement at approximately 6 months before KTx and with 
the second one performed approximately 2 years after successful KTx. 
With this restriction 17 pairs of measurements were available. 
Measures
Data and data collection 
Date of birth, gender, weight, height, serum creatinine, hemoglobin, 
blood pressure, medications, cause of ESRD, type of dialysis therapy, 
donor type (live or cadaveric), and time from KTx were extracted from the 
medical records. Estimated GFR (eGFR) was calculated using the original 
Schwartz formula (eGFR=k x height/serum creatinine; Schwartz et al. 
1976) as the Jaffe method was used for the measurement of creatinine. 
The recently published Schwartz formula was not fitting suitably as it is 
recommended for an enzymatic measurement of creatinine (Schwartz et 
al. 2009). Systolic and diastolic blood pressure (SBP, DBP) were measured 
using an auscultatory method with an appropriate cuff size, the lowest 
measurement was used for analysis. Blood pressure over the 95th percentile 
for age, gender and height defined hypertension (National High Blood 
Pressure Education Program Working Group on High Blood Pressure in 
Children and Adolescents 2004). Uncontrolled hypertension was defined 
as blood pressure over this 95th percentile despite taking antihypertensive 
medication. Anemia was defined as hemoglobin below 5th percentile for 
age and gender (Koshy 2008). Overweight status was defined as previously 
suggested as BMI over 85th percentile (Barlow et al. 2007). 
LVM was measured by a two-dimensionally guided and M-mode 
echocardiography (Esaote, MyLab50XVision), by one person, according to 
the criteria of the American Society of Echocardiography (Devereux and 
Reichek 1977). The LVM index (LVMI) was calculated by indexing of LVM 
to height2.7, as described previously (DeSimone et al. 1992). In this study, 
LVH was defined as an LVMI greater than the 95th percentile for normal 
children and adolescents (DeSimone et al. 1995). A cutoff of 45.0g/m2.7 
was used for boys and 40.0g/m2.7 for girls older than 9 years. In children 
younger than 9 years 95th percentiles were assessed according to the 
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recently published age-specific reference data (Foster et al. 2008; Khoury 
et al. 2009). Severe LVH was defined as LVMI >51g/ m2.7(Bullington et al. 
2006). A clinically important change in the LVMI was defined as a relative 
change of greater than 20% from the baseline value (Mitsnefes et al. 2001). 
Relative wall thickness (RWT) was measured to assess the LV geometric 
pattern (Ganau et al. 1992). Patients with a LVMI >95th percentile and 
elevated RWT (>0.41) had a concentric LVH, those with a LVMI >95th 
percentile and normal RWT (<0.41) had an eccentric LVH. Concentric 
remodeling was defined as an elevated RWT, but with a normal LVMI.
Statistical analyses
First, we assessed background characteristics of the sample. Second, we 
assessed the LVMI and the presence/absence of LVH. Third, we assessed 
whether successful transplantation was associated with major changes 
in LVMI and compared LVMI between patients with and without risk 
factors. We used paired Mann Whitney U-tests to compare means for 
continuous variables pre- and post-transplant, and Fisher's exact test 
for categorical variables. A p-value of <0.05 was considered statistically 
significant. Values are expressed as the mean ± standard deviation. SPSS 
20.0 and SAS 9.1 were used for the statistical analyses.
Results
Characteristics of the patients
Seventeen patients (10 males) were enrolled in this study, 9 with 
congenital primary renal disease. Eleven patients were treated by means 
of hemodialysis (HD), 1 was on peritoneal dialysis (PD) and in 5 patients 
both modalities were used before KTx. The average time spent on dialysis 
before KTx was 19±6months and the average age at transplantation 
was 11.3±3.6 years. None of the patients included was transplanted 
pre-emptively, two received a graft from a living donor. All patients 
were receiving immunosuppressive therapy consisting of steroids and 
calcineurin inhibitors (2x cyclosporine, 15x tacrolimus) or sirolimus (1x) 
and mycophenolate (17x). Three patients had overcome a biopsy proven 
acute allograft rejection. The initial echocardiography was performed at 
a mean of 6.6±1.9 months before KTx and the follow-up echo at 25.0±3.4 
months after KTx. At that time patients were taking on average 2.1 and 1.7 
antihypertensive drugs per patient respectively. No significant changes 
in the number of cases with uncontrolled hypertension, overweight and 
anemia were present over this period (Table 7.1). 
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Table 7.1 Characteristics of patients with echocardiographic measurement before and after KTx
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Table 7.1 Characteristics of patients with echocardiographic measurement before and after KTx 





Age, years 10.6±3.6 13.2±3.6 <0.001 
Time from KTx, months -6.6±1.9 25.0±3.4 <0.001 
Uncontrolled systolic hypertension 5 (29.4%) 6 (35.3%) 0.03 
Uncontrolled diastolic hypertension 4 (23.5%) 3 (17.6%) 0.12 
Overweight 1 (5.9%) 3 (17.6%) 0.18 
Anemia 5 (29.4%) 4 (23.5%) 0.05 
CaxP >4.4 4 (23.5%) 0 (0.0%) n.a. 
KTx – kidney transplantation; GFR – glomerular filtration rate; BP – blood pressure; BMI – body mass index; CaxP – calcium 
phosphate product; n.a. – not applicable 
 









IVSd, cm 0.83±0.16 0.89±0.17 0.03 
LVEDiD, cm 3.95±0.69 4.32±0.69 <0.001 
LVPWd, cm 0.65±0.13 0.72±0.14 0.23 
RWT, cm 0.34±0.08 0.33±0.04 0.80 
LVMI, g/m2.7 39.1±13.6 37.2±11.6 0.51 
LVH (n, %) 4 (23%) 5 (29%) 0.05 
LV geometry (n, %)    
   Concentric LVH 0 (0%) 0 (0%) n.a. 
   Eccentric LVH 4 (23%) 5 (29%) 0.05 
   Concentric remodeling 1 (6%) 1 (6%) 1.00 
   Normal 13 (77%) 12 (71%) 0.28 
KTx – kidney transplantation; IVSd – interventricular septal thickness at diastole; LVEDiD – left ventricular end-diastolic 
diameter; LVPWd – left ventricule posterior wall thickness at diastole; RWT – relative wall thickness; LVMI – left ventricular 
mass index; LVH – left ventricular hypertrophy; n.a. – not applicable 
KTx – kidney transplantation; GFR – glomerular filtration rate; BP – blood pressure;  
BMI – body mass index; CaxP – calcium phosphate product; n.a. – not applicable
Left ventricular hypertrophy and echocardiographic indices 
The average prevalence of LVH in patients while on dialysis was 23.5%, 
and it was 29.4% after KTx (p=0.06) (Table 7.2). However, per patient 
substantial changes occurred (Figure 1). Out of 4 children who initially 
had LVH (2 severe LVH), 1 converted to normal LVMI. Out of 13 children 
with initially normal LVMI while on dialysis, two developed LVH after 
transplantation (one of them severe LVH). Of the two patients who 
initially had severe LVH 1 continued to have severe LVH at the second 
evaluation, the other one improved but continued to have LVH. One more 
patient had severe LVH at the second evaluation, in this patient LVH was 
not present before KTx.
The prevalences of the subtypes of LVH (concentric or eccentric) 
before and after KTx did not change significantly. LVMI changed more 
than 20% in 6 patients (35.3%; 4 times decreased, 2 times increased; Figure 
1), but the change of the mean LVMI overall was not significant (39.1± 
g/m2.7 vs. 37.2± g/m2.7, =0.51). A significant increase in the mean value 
of the interventricular septum thickness (IVS) and left ventricular end-
diastolic diameter (LVEDD) was observed after KTx. 
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Table 7.2 Echocardiographic parameters in patients before and after KTx
72 
 
Table 7.1 Characteristics of patients with echocardiographic measurement before and after KTx 





Age, years 10.6±3.6 13.2±3.6 <0.001 
Time from KTx, months -6.6±1.9 25.0±3.4 <0.001 
Uncontrolled systolic hypertension 5 (29.4%) 6 (35.3%) 0.03 
Uncontrolled diastolic hypertension 4 (23.5%) 3 (17.6%) 0.12 
Overweight 1 (5.9%) 3 (17.6%) 0.18 
Anemia 5 (29.4%) 4 (23.5%) 0.05 
CaxP >4.4 4 (23.5%) 0 (0.0%) n.a. 
KTx – kidney transplantation; GFR – glomerular filtration rate; BP – blood pressure; BMI – body mass index; CaxP – calcium 
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   Eccentric LVH 4 (23%) 5 (29%) 0.05 
   Concentric remodeling 1 (6%) 1 (6%) 1.00 
   Normal 13 (77%) 12 (71%) 0.28 
KTx – kidney transplantation; IVSd – interventricular septal thickness at diastole; LVEDiD – left ventricular end-diastolic 
diameter; LVPWd – left ventricule posterior wall thickness at diastole; RWT – relative wall thickness; LVMI – left ventricular 
mass index; LVH – left ventricular hypertrophy; n.a. – not applicable 
KTx – kidney transplantation; IVSd – interventricular septal thickness at diastole; LVEDiD – left 
ventricular end-diastolic diameter; LVPWd – left ventricule posterior wall thickness at diastole; 
RWT – relative wall thickness; LVMI – left ventricular mass index; LVH – left ventricular 
hypertrophy; n.a. – not applicable
Figure 7.1 Intraindividual changes of left ventricular mass index after KTx.
Dx - dialysis





















The values of LVMI associated with the absence or presence of clinical 
variables are shown in Table 7.3. Male gender and uncontrolled systolic 
hypertension were associated with a higher LVMI with statistical 
significance.  
Table 7.3 LVMI and clinical variables in 34 measurement points
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LVMI – left ventricular mass index; CKD – chronic kidney disease   
 LVMI LVMI  P value 
Gender; males/females 43.3±12.2 28.8±6.1 <0.001 
Systolic hypertension; un/controlled 53.5±13.4 37.7±10.3 0.04 
Diastolic hypertension; un/controlled 47.1±19.2 38.6±8.7 0.22 
Anemia;  +/-  44.6±10.5 36.7±11.7 0.13 
Overweight; +/-  53.7±9.3 38.5±11.2 0.07 
CaxP; >4.4 / <4.4 41.5±15.7 39.8±11.5 0.77 
CKD; stage 5 / stage 1-4 39.1±13.6 38.9±11.2 0.97 
LVMI – left ventricular mass index; CKD – chronic kidney disease  
Discussion  
We followed the changes in LVMI in children and adolescents with ESRD 
over time, connected them with successful KTx and assessed whether 
clinical variables were associated with LVMI. We found that LVH remains 
a common problem in ESRD children and adolescents even after a 
successful KTx, and that overall the prevalence of LVH did not change 
significantly after transplantation. On dialysis, 23.5% of children had LVH 
compared to 29.4% after KTx .On the individual level substantial changes 
occur. Six out of 17 patients (35.3%) had a change in LVMI of more than 
20% after KTx (four improvements and two worsenings).
Published prevalences of LVH in CKD children vary widely, 
from 8 to 82% (Johnstone et al. 1996; Matteucci et al. 1999; Kaidar et al. 
2014; Mitsnefes et al. 2001). To a considerable extent differences among 
studies may be explained by the cutoff used regarding LVH. Recently 
published cutoffs to define differences from the norm based on age and 
gender specific 95th percentiles as used were used in this study to denote 
LVH (Foster et al. 2008; Khoury et al. 2009). Studies using this more 
conservative approach have reported rather similar prevalences as ours 
(Becker-Cohen et al. 2008; Kaidar et al. 2014). Use of the old criteria in our 
study would have led to a prevalence of 41.2% and 47.1% before and after 
KTx, respectively (Daniels et al. 1995). 
Significant changes of LVMI over time on the individual level have 
been described previously as well (Mitsenefes et al. 2001; Mitsnefes 2004; 
Bullington et al. 2006). The core issue, the predictors of the change of LVM, 
are however not yet understood. One might assume that a substantial 
increase in glomerular filtration rate after KTx would per se lead towards 
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a considerable regression of hypertrophy in a vast majority of the 
individuals. However, only studies of Becker-Cohen showed a substantial 
overall decrease of LVMI after KTx (Becker-Cohen et al. 2006; Becker-
Cohen et al. 2008). This decrease was shown to be a consequence of good 
blood pressure control, not the result of improvement of uremic milieu 
per se (Becker-Cohen et al. 2008). In our study a significant increase of 
eGFR after KTx was not associated with significant improvement of LVMI 
(Table 7.1) and no association of LVMI with eGFR was present regardless 
of patient status (with or without graft; Table 7.3). In contrast, findings 
of a big Dutch sample of 140 young adults with ESRD from childhood 
have confirmed that LVMI is significantly higher in patients with poor 
functioning grafts using a cutoff of 25ml/min/1.73m2 (Gruppen et al. 
2003). Foley and Alvarez have emphasized the malignant influence of 
the prolonged uremia onto the myocardial architecture what underlines 
the essential importance of a short waiting time for KTx(Foley et al. 
1995; Alvares et al. 1998). Also the duration of the course of CKD before 
establishing renal replacement therapy may play a fundamental role in 
the development of LVH (Weaver et al. 2009). 
In adults, LVMI correlates with height, lean body mass, BMI, blood 
pressure, hemoglobin and other factors (Foley et al. 1995; Liao et al. 1997; 
Devereux and Roman 1999). In children, increasing height and lean 
body mass seems to be a driving force of growth of the mass of the left 
ventricle, but less is known about the factors and mechanisms and their 
importance under pathologic circumstances e.g. CKD, due to its relatively 
rare occurrence in children (DeSimone et al. 1995; Daniels et al. 1995). In 
our study, patients with uncontrolled systolic hypertension were found 
to have significantly higher LVMI. This is in accordance with the largest 
pediatric study on LVH after KTx which showed a relative risk for LVH 
of 19.7 in hypertensive patients (p=0.004) (El-Husseini et al. 2004). Also 
studies of Becker-Cohen et al., Johnstone et al. and Kitzmueller et al. 
found a relation between LVMI and BP and emphasized that good blood 
pressure control after KTx may lead to a decrease of LVH prevalence 
(Johnstone et al. 1996; Becker-Cohen et al. 2006; Kitzmueller et al. 2004). 
On the other hand Matteuci et al. reported a very high prevalence of 
LVH (82%) despite a relatively low prevalence of hypertension (36%) 
what might suggest the importance of other factors. They themselves 
hypothesized that hypertension may not be sufficient for the development 
of LVH in recipients of grafts (Matteucci et al. 1999). However, a higher 
cutoff for denoting LVH may have added to over-attribution of LVH in 
that study. Finally, the previously mentioned Czech study surprisingly 
did not find relation of blood pressure and LVH even with 24 hour 
ambulatory blood pressure monitoring (Seeman et al. 2006). In sum, most 
of the studies relate hypertension with LVH although data are scarce and 
sometimes contradictory.
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No association between LVMI and overweight was found in our 
sample. In the study of Bullington et al. BMI independently predicted 
the presence of LVH, what was explained as being a consequence of 
hypercirculation frequently seen in overweight individuals (Bullington et 
al. 2006). Studies comparing LVMI in obese hypertensive children and in 
those with hypertension alone showed higher LVMI in obese individuals 
(Hanevold et al. 2004; Richey et al. 2010). The influence of BMI was, 
however, not found in the pediatric study of Becker-Cohen (Becker-Cohen 
et al. 2008).
In this study anemia was found to have no clear association with 
LVMI. In our previous study anemia had a statistically borderline relation 
with the increased serum level of brain natriuretic peptide, a marker of 
heart remodeling. A bigger sample size might have yielded statistical 
significance as in the study of El-Husseini et al. who showed anemia to 
independently predict the development of LVH. An eccentric pattern of 
LVH, that was shown to be a consequence of anemia according to some 
studies, dominated in our sample. This was similar to the studies of 
Mitsnefes et al. and Bullington et al. where the eccentric pattern of LVH 
was more common than the concentric one even after improvement in 
the anemia prevalence at the follow-up (Greaves et al. 1994; Hayashi et al. 
2000; Mitsnefes et al. 2001; Levin 2002; Bullington et al. 2006). 
Strengths and limitations  
A strength of this study is that it covers all patients from one region of 
eastern Slovakia although the number of patients for analyses was small. 
Information is based on the records from one center which led to large 
consistency in the way of recording. A limitation was that blood pressure 
was not measured by means of 24 hour ambulatory blood pressure 
monitoring. The effect of KTx may change in time due to better care, 
thus perhaps some underestimation may have occurred of the effects of 
current KTx.
Implications
We found that LVH is a common problem after pediatric KTx. Although we 
did not find a major change in LVMI after KTx overall, we found relatively 
many changes at the individual level. This suggests differences in control 
of risk factors for the development of LVH. Thus, rigorous management 
of (systolic) blood pressure and possibly anemia or other risk factors 
may have a positive impact on cardiovascular morbidity and mortality 
in recipients of KTx in childhood and adolescence. Larger longitudinal 
studies are needed to precisely identify the impact of uncontrolled BP, 
anemia, obesity and other factors and its duration on geometry of LV 




In summary we demonstrated that LVH is common after pediatric 
KTx. Despite the overall poor reversibility of LVH after transplantation 
significant changes of LVMI are present on the individual level which 
might be explained by a different control of (systolic) hypertension and 
other risk factors.
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This study focused on the epidemiology in children with kidney diseases 
and added to the existing knowledge about its determinants, in particular 
Roma ethnicity, and its outcomes. Our findings concerned the occurrence 
of end-stage renal disease (ESRD) in children in Slovakia and added 
to the understanding of its determinants and outcomes. This chapter 
summarizes and discusses the main findings of our study, examines its 
strength and limitations and finally indicates implications for practice as 
well as possibilities for further research.
8.1 Main findings
Research question 1 (Chapter 3):
What are the actual incidence and prevalence rates of ESRD and renal replacement 
therapy(RRT) in Slovak children; what are the differences in the results regarding 
2003–2009 compared with those from earlier epidemiological surveys carried out 
in Slovakia; what are the incidence and prevalence rates of ESRD and RRT in 
Slovak children compared with those of children from other European countries; 
what is the etiology, i.e., primary renal diseases and treatment modes, compared 
with earlier studies on Slovak children and with children from other European 
countries. 
We examined the occurrence of ESRD in Slovak children over the years 
2003–2009 and compared it with earlier Slovak data and with data from 
other European countries and explored its etiology. We found the median 
annual incidence rate of ESRD in Slovak children under 15 years of age 
was 6.6 per million age-related population (pmarp). The prevalence rate 
on 31 December 2009 was 24.1 pmarp. The study showed that during the 
past decade, the incidence and prevalence rates of ESRD in Slovak children 
remained stable. Compared with the last study on Slovak children (18.6 
pmarp), the differences were not statistically significant, but they were 
significantly higher compared to the first Slovak study published in 1978. 
The comparison with neighboring countries and with the European 
average showed no significant difference in incidence, while prevalence 
was significantly lower compared to neighboring Austria and some other 
(mostly western) European countries as well as the European average.
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Research question 2 (Chapter 4):
What is the difference in occurrence of ESRD between Roma and non-Roma and 
what is the relative risk (RR) of Roma for ESRD by age groups? 
We found that the risk for ESRD is significantly higher for Roma than 
for non-Roma. The RR of ESRD for Roma was 1.34, compared to the 
majority population. After age standardization, the RR for Roma was 2.85. 
A genetic propensity of Roma to renal failure may partially explain the 
higher risk. Moreover, a poorer control of risk factors for ESRD in Slovak 
Roma contributes to the increased risk.
Research question 3 (Chapter 5):
What is the share of Roma and non-Roma in a tertiary nephrology clinic for 
children compared with that in the general population, and secondly what is the 
share of Roma and non-Roma regarding early signs of primary renal diseases 
(PRD) and specific PRD? 
We found that the share of Roma among patients was small regarding early 
signs like proteinuria but big regarding PRD with gross clinically apparent 
symptoms (e.g. Alport syndrome and systemic lupus erythematosus). In 
other words we found that the overall share of Roma children among 
patients with kidney problems is lower than their estimated share in the 
population of the same age, in particular for early signs, but not for major 
diseases. 
Research question 4 (Chapter 6):
What is the occurrence of renal injury as defined by presence of severely increased 
albuminuria, hypertension and/or decrease of glomerular filtration rate (GFR) 
<60ml/min/1.73m2 in solitary functioning kidney (SFK) children? 
We found that a substantial proportion of children with SFK develop 
renal injury during childhood, especially those with CAKUT in the SFK. 
Therefore, close follow-up of albuminuria, blood pressure and eGFR are 
warranted to identify chronic kidney disease in its early stages.
Research question 5 (Chapter 7):
What is the prevalence of left ventricular hypertrophy (LVH) in ESRD children 
before and after transplantation and what clinical variables are associated with 
its changes?
Our study showed that LVH persists after successful kidney transplantation. 
However, on the individual level LVH changes considerably after 
successful transplantation, but this may concern both an improvement 
and a worsening. An explanation for this individual variability may be 
that the control of risk factors for LVH after transplantation varies.
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8.2 Discussion of the main findings
Epidemiology of CKD/ESRD in children from a European perspective 
We found an increase in the prevalence of ESRD in Slovakia during the 
past decades, whereas regarding the incidence we could not assess a trend 
because the first study on the epidemiology of CKD in Slovak children 
only described its prevalence (Zvara et al. 1978). In the years covered by 
the first study (1975 to 1977) most cases of ESRD died (undiagnosed) and 
no records are available to compare the incidence with the current one. 
A real increase of the incidence of the last stage of CKD (i.e. ESRD) may 
have occurred due to a better survival of earlier stages of CKD in case of 
formerly lethal diseases e.g. autosomal recessive polycystic kidney disease 
or congenital nephrotic syndrome. The increase in prevalence is probably 
partially due to an increase in incidence. However, in addition a better 
survival is likely to be a major determinant. The increased availability 
of dialysis and kidney transplantation for children at an increasingly 
younger age and improved care (e.g. better skilled specialized personal, 
better equipment and elimination of existing communication barriers) has 
added to this. 
Explanations of the relatively lower prevalence of ESRD compared 
with that of western countries are probably similar. A lower prevalence 
may theoretically be due to either relatively few new cases, i.e. a low 
incidence, or to relatively many cases that die early, i.e. a high lethality. As 
we found the current incidence to be rather similar to that of neighboring 
countries, the only remaining explanation for this lower prevalence is a 
higher lethality of ESRD in patients in Slovakia. Despite the improvement 
in survival of dialyzed and transplanted children in Slovakia it still seems 
to be lagging behind the western countries, i.e. those western countries 
are improving quicker or keep their previous advantage. This may be 
interpreted as that in Slovakia care for this type of problems still needs 
investments to improve quality. As such, it may relate to the relatively low 
share of the gross domestic product (GDP) spent on healthcare. In Slovakia 
8.1% of the GDP is spent on healthcare in contrast to an average 9.3% for 
all OECD countries, and moreover the Slovak GDP per inhabitant is much 
lower than the OECD mean (Organisation for Economic Co-operation and 
Developement 2014). In addition, differences in organization of care and 
training of personal may contribute to these differences. 
Findings on CKD and Roma 
We found that the proportion of Roma among children with CKD stages 
1-4 is lower compared with that of the majority population, which is in 
sharp contrast with our finding of a very high proportion of Roma among 
children with ESRD (CKD stage 5) (Kolvek et al. 2012; Kolvek and Podracka 
2012). The proportion of Roma was also relatively much larger in case of 
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some diseases, but this concerned mostly rare diseases. Associated with 
this, the relative risk (RR) for prevalent ESRD was several times higher for 
Roma (2.85 after age standardization) and the population’s attributable 
risk for ESRD due to Roma having ESRD was estimated as 37.4 %, i.e. 37.4 
% of all cases of ESRD in Slovak children was due to the excess risk in 
Roma what causes a significant additional burden of disease. 
Our findings fit with recent findings showing that relatively 
deprived ethnic minority groups including Roma have a higher risk for 
ESRD. In 2014, a study on adult (Slovak) Roma was published which 
supported our findings of Roma being a risky population for kidney 
diseases (Rosenberger et al. 2014). Similarly Hungarian authors found that 
Roma ethnicity is independently associated with an increased mortality 
risk and worse graft outcome in kidney transplant recipients (Molnar et 
al. 2012). To the best of our knowledge these studies represent the only 
evidence published on Roma with kidney problems. However, higher 
rates of occurrence of CKD/ESRD have been shown in relatively deprived 
ethnic minorities for many parts of the world. Australian Aborigines and 
African Americans can serve as good examples (McDonald et al. 2010; 
U.S. Renal Data System 2009). CKD patients of Afro-American ancestry 
were shown to show-up late in the course of their CKD (Ifudu et al. 1999). 
Published evidence also shows that Indo-Asian immigrants in the United 
Kingdom (UK) have approximately 3–5 times higher incidence rates of 
ESRD compared to the majority population in the UK (Lightstone 2003). 
The Roma ethnic group is believed to have come to Europe from the Indian 
subcontinent (Zeman et al. 2003). This higher risk in native inhabitants of 
India thus fully fits with our findings.
The increased risk for ESRD in Roma may be due to a number of 
factors. First, their risk for CKD and ESRD in general seems to be higher 
due to specific factors, such as socio-economic circumstances, hygiene, 
health behaviors, and genetic constitution. E.g. a higher occurrence of 
infections in developing countries was shown to lead to a higher occurrence 
of glomerulonephritides (Hurtado and Johnson 2005). Regarding health 
behaviors, e.g. smoking during pregnancy and inappropriate nutrition 
of pregnant women have been documented to happen relatively more 
frequently in Roma (Bobak et al. 2005; Rambouskova et al. 2009; Balazs 
et al. 2013). These have a clear relation to low birth weight infants when 
compared to the Slovak standards (Rimarova et al. 2004), and consequently 
the number of nephrons, the building units of the kidney, is lower 
(Brenner and Chertow 1994). Moreover, a different genetic constitution 
may explain a part of increased risk for CKD/ESRD in some populations 
including Roma. This may occur via a higher incidence of specific PRDs, 
as well as a quicker progression of the disease into ESRD (Patzer and 
McClellan 2012). This also relates to the increased prevalence of diabetic 
nephropathy in ESRD Roma as we found in our study on adults. The 
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differences in genetic constitution might explain the higher incidence of 
diabetes mellitus in Roma and/or possibly poorer control of the disease 
leading to more frequent premature organ damage compared to that in 
the majority population. In case of pediatric patients with ESRD a higher 
consanguinity in Roma may add too as most of the PRDs in children 
are congenital or hereditary in nature (often with recessive inheritance) 
(Thomas et al. 1987; Ferak et al. 1987; Martinez-Frias and Bermejo 1992; 
Gabrikova et al. 2013).
In addition to that, entry to care seems to be relatively late in the 
Roma ethnic group. Several studies were published on Roma that showed 
them to have a lack of means, problems with transportation and to be 
discriminated (Erasmus MC-University Medical Centre Rotterdam 
Rotterdam 2007; Kolarcik et al. 2012; Babinska et al. 2013; Jarcuska et al. 
2013; Sudzinova et al. 2013). Though none of the studies so far conducted 
focused on Roma kidney diseases, determinants of poor access to care 
may be expected to be pretty similar as for other diseases. The same holds 
for another issue regarding access, i.e. the attitude of Roma towards their 
own health and the health of their children. Studies comparing Roma 
with non-Roma have shown that Roma perceive the relationship between 
lifestyle and health much less as being strictly causal; issues of health and 
disease are interpreted rather fatalistically (Vivian and Dundes 2004; Petek 
et al. 2006; Van Cleemput et al. 2007). Evidence on the degree to which 
this affects the way Roma care for their children is completely lacking. 
A third and possibly crucial reason why Roma children show up only 
after obvious clinical symptoms have developed is a poor understanding 
of the disease by their parents, leading them not to respond to early signs 
(Koupilova et al. 2001). 
One would assume that the Roma-effect would logically lead to 
a relatively higher occurrence of ESRD in Slovakia overall compared 
to Western Europe. Surprisingly the opposite is true, at least regarding 
children in Slovakia for whom we found that the occurrence of ESRD 
was relatively lower than elsewhere. In the category of 0-14 years olds the 
standardized RR for ESRD in Roma was found to be 1.82. An explanation 
for this discrepancy may be that to a certain extent the high occurrence of 
ESRD in other deprived minorities which are relatively overrepresented 
in Western Europe may compensate for the high occurrence of ESRD in 
Slovak Roma. However, data on minority children in these other countries 
are scarce (Harambat et al. 2012), so this requires further confirmation. 
Solitary functioning kidney patients as a potential risk group for CKD/ESRD
We found that a substantial proportion of children with solitary 
functioning kidney (SFK) developed renal injury during childhood, 
especially those with structural anomalies in the SFK. Our findings are 
in line with those of a recent Dutch study on a large sample of children 
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(Westland et al. 2013), whereas findings of other studies vary from hardly 
any injury to frequent injury (Robitaille et al. 1985; Argueso et al. 1992a, 
Argueso et al. 1992b; Seeman et al. 2006; Sanna-Cherchi et al. 2009; Abou 
Jaoude et al. 2010). It is interesting that adult living-kidney donors who 
have a SFK are frequently shown to have a stable renal function over more 
than 25 years after nephrectomy (Hakim et al. 1984; Najarian et al. 1992; 
Goldfarb et al. 2001), while in children with SFK this is much less clear, 
with controversies regarding renal function. The selection of apparently 
healthy adult donors may be the explanation for this phenomenon 
(Chevalier 2009), while in case of children, variations in the shares of 
patients with structural anomalies in SFK among studies might explain 
the heterogenic findings. With this regard longitudinal follow-up studies 
like the Westland’s and ours, which followed albuminuria prospectively, 
might be able to identify poorly faring children in early stages of disease 
already. In addition, this heterogeneity could also be due to differences in 
care, but in case of SFK there is a general lack of treatment options and it 
is unclear which patients would benefit from potential treatment anyhow. 
Cardiovascular outcomes in ESRD children 
We found that left ventricular hypertrophy (LVH) persists even after 
successful kidney transplantation. This may be interpreted as a limited 
reversibility of LVH. However, at individual level the variability in LVH 
was rather large, suggesting that modification is feasible but varies 
per person. The differences might be explained by differences in the 
control of hypertension, anemia and other risk factors. Previous studies 
found various predictors of the development of LVH (Johnstone et al. 
1996; Matteucci et al. 1999; Mitsnefes et al. 2001; Kitzmueller et al. 2004; 
Bullington et al. 2006; Becker-Cohen et al. 2008). These factors could then 
offer an explanation for the variability at the individual level that we 
found. Rigorous management of post-transplant hypertension and anemia 
may have positive impact on cardiovascular morbidity and mortality in 
recipients of KTx in childhood and adolescence.
8.3 Strengths and limitations
A major strength of our study is that we employed several samples that 
were mostly included in full, i.e. without non-response. Even in case of 
studies with a limited number of patients, for on SFK and LVH, these 
covered all children in a full area of eastern Slovakia. The influence of 
ethnicity on CKD/ESRD was studied in a sample covering several years 
regarding a country with a large Roma minority which may limit the 
likelihood of only including specific subsamples of Roma. Although 
we did not have a full national coverage on ethnicity, we could estimate 
the share of the population covered by our study very accurately, both 
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regarding size and age-distribution (Vano 2002; Statistical Office of Slovak 
Republic 2011). 
Data for all our studies were retrieved from medical records, 
which means that our findings may have been affected by incomplete or 
incorrect recording. We have no estimate of the degree to which this may 
have occurred, but in general underregistration seems to be more likely 
than overregistration, implying some underestimation of prevalences in 
our study. Regarding the occurrence of ESRD a limitation might be that 
the number of ESRD patients was assessed based on the number of RRT 
patients. However, current treatment guidelines and the good availability 
of treatment facilities make it rather unlikely that this would have led to 
missing many patients. If so, this will probably most affect the Roma group, 
implying that the already high rate of ESRD in Roma children is actually 
even higher. Bias may also have occurred in the study on SFK children. 
This cohort included relatively many children who were referred because 
they showed symptoms. Therefore, our findings may overestimate the 
negative consequences of SFK due to an overrepresentation of poorly 
faring children. 
8.4 Implications for practice and policy, and for research
Our findings have several implications for practice and policy, and for 
research.
Implications for practice and policy
We found that the prevalence of ESRD was much higher among Roma 
while Roma were underrepresented in earlier stages of CKD. This 
suggests that access of Roma to care should be improved. This access 
may be improved via interventions at both the side of the patients and 
its setting, and at the side of the professional and the health care system 
(Belak 2013; Bosakova 2013). Specifically interventions should focus on 
segregated Roma settlements, as these are the Roma living settings with 
the poorest living conditions and the poorest educational status of the 
residents. Regarding the patient, health literacy should be improved, 
which may improve both adherence to preventive care and to treatment 
(Sørensen et al. 2012). Professionals should be aware of the unique health 
beliefs of Roma (Thomas 1985; Sutherland 1986; Roman 2013; Roman 
2014). Understanding cultural differences together with decreased 
communication barriers may lead to an increased faith of Roma into the 
“Gadje” medical system (Sutherland 2002). Occasionally discrimination 
towards Roma from the side of professionals may be the cause of 
problematic access, and specific attention should therefore be paid to this 
issue in graduate and postgraduate training of the professionals involved 
in this case. 
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The other modifiable factors responsible for the higher risk of ESRD 
in Roma may be poor hygiene and nutrition. Increased hygiene in the 
settlements might have a significant impact on the overall epidemiology 
of CKD as the hygiene hypothesis seems to be the culprit behind the 
decreased occurrence of glomerulonephritides in the western world 
compared to the developing countries (Hurtado and Johnson 2005). 
Some ethnic minorities including Roma were shown to have lower birth 
weights (as a consequence of smoking and inappropriate nutrition during 
pregnancy) (Rimarova et al. 2004; Bobak et al. 2005; Rambouskova et 
al. 2009; Balazs et al. 2013) what was shown to have a direct impact on 
the kidney survival due to less nephrons (Brenner and Chertow 1994). 
Campaigns against smoking and interventions to improve the socio-
economic circumstances of Roma might indirectly lead to heavier infants 
with lower occurrence of CKD (Belak 2013). Furthermore stimulation of 
their employment might improve their socio-economic circumstances 
(Bosakova 2013).
We found that having just one (functioning) kidney (SFK) puts a 
child at risk for CKD as a substantial proportion of children with SFK 
developed renal injury during childhood. Clinicians should be aware of 
the unfavorable prognosis of certain subgroups of individuals having SFK 
from childhood. All SFK patients should be referred to specialized care for 
follow-up and potential identification of risks for unfavorable prognosis 
(e.g. structural anomaly in SFK) in that particular individual. Moreover, 
the difference with the excellent prognosis of healthy adult kidney donors 
should be emphasized to professionals, implying that SFK children need 
much more attention in care. The excellent prognosis of adult donors is 
probably the result of a positive selection (i.e. individuals with risks are 
not allowed to become donors as a rationale behind transplantation is 
to treat a diseased individual and at the same time to avoid as much as 
possible producing another one at risk for RRT). Regarding children with 
SFK the prognosis is potentially in particular unfavorable in a subgroup 
of patients with structural anomalies. However, evidence on this is still 
scarce, and other factors might have an important role as well. Regular 
check-ups are warranted monitoring albuminuria, blood pressure and 
glomerular filtration rate to detect consequences early when well aimed 
intervention may have some impact on the prognosis.
We found that even with successful transplantation, as a treatment 
of choice for ESRD, the increased cardiovascular risk persists. LVH, 
a surrogate marker of cardiovascular risk, was shown to be common 
even after successful transplantation. This is an important message for 
clinicians: successful kidney transplantation is not a full solution, at least 
not in terms of cardiovascular risk even though risks are clearly lower in 
transplanted individuals (U.S. Renal Data System 2011). The reversibility 
of already present LVH seems to be rather problematic. An effort should 
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be put on the meticulous management of hypertension and anemia and 
other factors like overweight that where clearly shown to have a relation 
with LVH in adults. The registry of ESRD patients that has been recently 
established in Slovakia could be a helpful tool for monitoring and 
consequently improving the quality of health care and quality of life of 
these children.
Implications for research
Our findings show that further research is needed into the excess 
risk of Roma for CKD/ESRD in order to target interventions aiming 
at improvement more accurately. Specifically, studies identifying 
the pathways leading to the excess risk are needed (Reijneveld 2010). 
With this regard epidemiological research should cover also earlier 
stages of CKD. Furthermore, research should focus on the differences 
between the marginalized Roma populations living in the settlements 
versus Roma populations that are more integrated into the majority 
population as significant differences might be expected. How Roma 
care for their children and how they understand what they are told 
by clinicians and in preventive message might offer new routes for 
improvement. Another issue potentially leading to a considerable 
benefit might be the research of ethnic differences in polymorphisms 
of the genes which are thought to be associated with the progression 
of CKD (O‘Seaghdha and Fox 2011).
With regard to the patients with SFK the scientific community is in 
anticipation of the possibility to measure the number of nephrons in vivo. 
This might be promising as low nephron endowment has been shown to 
put individuals at risk for CKD progression. This phenomenon, however, 
has not sufficiently been studied in SFK children (Schreuder and Nauta 
2007).  
Close longitudinal follow-up of cardiovascular system of ESRD 
patients should continue to better identify the risk factors for the 
development of LVH to target at. More strict control of these factors might 
lead to improvement of echocardiographic parameters and potentially 
decrease the overall mortality. Whether this indeed is the case deserves 
further study. 
8.5 Conclusion
This thesis dealt with epidemiology in children with kidney diseases. We 
described the occurrence of ESRD in children in Slovakia. Our findings 
added to the understanding of its determinants and outcomes. We showed 
that a) during the past decade, the incidence and prevalence rates of ESRD 
in Slovak children have remained stable and compared to the European 
average, the prevalence in Slovak children is significantly lower; b) Roma 
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ethnicity is associated with a significantly higher risk for ESRD; c) the 
proportion of Roma in a tertiary nephrology clinic for children is overall 
significantly lower compared to what might be expected based on their 
proportion in general population; d) a substantial proportion of children 
with SFK develop renal injury during childhood, especially those with 
CAKUT in the SFK; and finally that e) the prevalence of LVH, a crucial 
risk factor for cardiovascular morbidity and mortality in ESRD children 
persists even after successful transplantation. This thesis shows that 
substantial health gains can be reached by improved prevention of and 
care for renal disorders in children. 
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Summary
This study focuses on the epidemiology of chronic kidney diseases 
(CKD) in children and tries to add to the existing knowledge about its 
determinants, in particular Roma ethnicity, and its prognosis. We studied 
a) the epidemiology of end-stage renal disease (ESRD) in Slovak children 
over time and in comparison with European data (Chapters 3); b) the 
influence of Roma ethnicity on the epidemiology of CKD/ESRD (Chapter 
4-5); and c) other potential risk factors for the development of CKD 
(Chapter 6) and an unfavorable prognosis of CKD (Chapter 7). 
Chapter 1 introduced the main topics of the study. Furthermore, the 
basic model on epidemiology, risk factors and outcomes was desribed and 
the five research questions were formulated that have been answered in 
this thesis.
Chapter 2 provided information about the samples, data sources, 
measures and statistical analyses used in the Chapters 3-7.
Chapter 3 described the trend in occurrence of ESRD over the past 
decades in Slovakia and put these a European perspective. Findings 
showed that during the past decade the incidence and prevalence 
rates of ESRD in Slovak children remained stable. The comparison 
with neighboring countries and with the European average showed no 
significant differences in incidence, while the prevalence in Slovakia was 
significantly lower than the European average.
Chapter 4 explored Roma ethnicity as a risk factor for ESRD. ESRD 
in children and adults was found to be significantly more prevalent in 
Roma than in non-Roma in all age groups. The relative risk (RR) for 
prevalent ESRD for Roma was 1.34 compared to the majority population. 
After age standardization, the RR for Roma was 2.85. This higher risk may 
be a consequence of a genetic propensity of Roma to renal failure and 
of a poorer control of other risk factors for ESRD in (Slovak) Roma, in 
particular those related to socioeconomic adversity.
Chapter 5 studied ethnic differences in the epidemiology of earlier 
stages of CKD. Overall, Roma were found to be relatively underrepresented 
in the earlier stages of CKD as opposed to their overrepresentation among 
patients with stage 5 CKD (i.e. ESRD). In case of specific relatively rare 
nephropathies Roma were overrepresented.  
Chapter 6 focused on children with a single functioning kidney (SFK) 
and assessed the occurrence of renal injury in these patients. A substantial 
proportion of patients with SFK was found to develop renal injury during 
childhood, especially the patients with a structural anomaly in their SFK. 
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Chapter 7 explored the epidemiology of cardiovascular consequences 
of ESRD, particularly left ventricular hypertrophy (LVH), before and after 
kidney transplantation. It showed that LVH persists even after a successful 
kidney transplantation, but that significant changes on the individual 
level occurred. This might be explained by varying control of risk factors, 
the most significant of which is hypertension.
Chapter 8 summarised the outcomes of the thesis, discussed them, 
argued their strengths and weaknesses, highlighted their implications 
for practice, and offered new possibilities for further research. Generally, 
we found that the occurrence of ESRD in children has not changed 
significantly over the past decade in Slovakia. Furthermore we found that 
Roma ethnicity is associated with a poorer development and progression 
of CKD. Furthermore, a substantial proportion of patients with SFK were 
found to develop renal injury during childhood. Finally we found that 
LVH persists even after successful kidney transplantation.
Future research should be focused on the excess risk of Roma for 
CKD/ESRD, particularly in the marginalized Roma settlements, in 
order to come to better targeted interventions aiming at improvement. 
Specifically studies identifying the pathways leading to the excess risk in 
Roma, to the deterioration of SFK, and to the persistence of LVH after 
kidney transplantation are needed. This study showed that substantial 




Deze studie richt zich op de epidemiologie van chronische nierziekten 
(CKD) bij kinderen en probeert bij te dragen aan de bestaande kennis over 
de determinanten ervan, in het bijzonder Roma etniciteit, en de prognose 
van CKD. We bestudeerden a) de epidemiologie van nierziekten in het 
laatste stadium (end-stage renal disease, ESRD) bij Slowaakse kinderen 
over de tijd en in vergelijking met de Europese gegevens (hoofdstuk 
3); b) de invloed van Roma afkomst op de epidemiologie van CKD/
ESRD (hoofdstuk 4-5); en c) andere potentiële risicofactoren voor de 
ontwikkeling van CKD (hoofdstuk 6) en een ongunstige prognose van 
CKD (hoofdstuk 7).
In Hoofdstuk 1 worden de belangrijkste onderwerpen van de 
studie ingeleid. Bovendien wordt een basismodel met betrekking tot 
epidemiologie, risicofactoren en uitkomsten beschreven en worden 
de vijf onderzoeksvragen geformuleerd die in dit proefschrift worden 
beantwoord.
Hoofdstuk 2 geeft informatie over de steekproeven, gegevensbronnen, 
meetinstrumenten en statistische analyses die worden gebruikt in de 
hoofdstukken 3-7.
Hoofdstuk 3 beschrijft de trend in het voorkomen van ESRD in de 
afgelopen decennia in Slowakije en zet deze in een Europees perspectief. 
Uit onze bevindingen bleek dat in de afgelopen tien jaar de incidentie 
en prevalentie van ESRD in Slowaakse kinderen stabiel is gebleven. De 
vergelijking met de buurlanden en met het Europese gemiddelde toonde 
geen significante verschillen in incidentie aan, terwijl de prevalentie in 
Slowakije significant lager was dan het Europese gemiddelde.
Hoofdstuk 4 gaat in op de Roma etniciteit als een risicofactor voor 
ESRD. ESRD bij kinderen en volwassenen bleek in alle leeftijdsgroepen 
significant vaker voor te komen bij Roma dan bij niet-Roma. Het relatieve 
risico (RR) voor de prevalente ESRD voor Roma was 1,34 in vergelijking 
met de meerderheid van de bevolking. Na de standaardisatie voor leeftijd 
was de RR voor Roma 2,85. Dit verhoogde risico kan een gevolg zijn 
van een genetische aanleg van Roma tot nierfalen en van een slechtere 
controle van andere risicofactoren voor ESRD bij (Slowaakse) Roma, in het 
bijzonder factoren die samenhangen met een lage sociaal-economische 
status.
In Hoofdstuk 5 werden de etnische verschillen in de epidemiologie 
van de vroegere stadia van CKD bestudeerd. Roma bleken relatief 
ondervertegenwoordigd in de vroegere stadia van CKD maar 
oververtegenwoordigd in de groep patiënten met CKD stadium 5 
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(ESRD). Wat betreft bepaalde relatief zeldzame nierziekten waren Roma 
oververtegenwoordigd.
Hoofdstuk 6 richtte zich op kinderen met een enkele functionerende 
nier (solitary functioning kidney, SFK) en het optreden van nierschade 
bij deze patiënten. Een aanzienlijk deel van de patiënten met SFK bleek 
nierschade al tijdens de kindertijd te ontwikkelen, vooral de patiënten 
met een structurele anomalie in hun SFK.
In Hoofdstuk 7 werd de epidemiologie van cardiovasculaire 
gevolgen van ESRD onderzocht, vooral linker ventriculaire hypertrofie 
(LVH), voor en na niertransplantatie. Het bleek dat LVH in het algemeen 
zelfs na een succesvolle niertransplantatie blijft bestaan, maar dat op 
individueel niveau de variatie aanzienlijk was. Dit kan verklaard worden 
door een verschil in controle van risicofactoren, waaronder hypertensie.
In Hoofdstuk 8 worden de resultaten van het proefschrift samengevat, 
en besproken. Er werd op ingegaan op de sterke en zwakke punten van het 
onderzoek, en op de implicaties ervan voor de praktijk, alsmede nieuwe 
mogelijkheden voor verder onderzoek. Over het algemeen vonden we dat 
het optreden van ESRD bij kinderen niet significant is veranderd in de 
afgelopen tien jaar in Slowakije. Verder vonden we dat de Roma etniciteit 
wordt geassocieerd met een slechtere ontwikkeling en progressie van CKD. 
Bovendien werd een aanzienlijk deel van de patiënten met SFK gevonden 
dat nierschade ontwikkelt tijdens de kindertijd. Tenslotte vonden we dat 
LVH blijft bestaan, zelfs na een succesvolle niertransplantatie. 
Toekomstig onderzoek moet zich richten op het verhoogde risico 
van Roma op CKD/ESRD, met name in de gemarginaliseerde Roma-
nederzettingen, om te komen tot beter omschreven interventies ter 
verbetering. In het bijzonder is onderzoek nodig dat zich richt op het 
identificeren van de paden die leiden naar het verhoogde risico bij Roma, 
naar de verslechtering van de SFK, en naar het voortbestaan  van LVH 
na een niertransplantatie. Deze studie laat zien dat een aanzienlijke 
gezondheidswinst kan worden bereikt door een betere preventie van en 
zorg voor nieraandoeningen bij kinderen.
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Zhrnutie
Práca opisuje epidemiológiu chronickej obličkovej choroby (CKD) 
v detskom veku, prináša nové poznatky o determinantoch ochorenia 
a zameriava sa na špecifiká CKD v rómskom etniku. Konkrétne sa 
zameriava a) na epidemiológiu terminálneho štádia chronickej obličkovej 
choroby (ESRD) slovenských detí a vývoj epidemiologickej situácie na 
Slovensku v kontexte s okolitými krajinami Európy (kapitola 3); b) na 
faktor rómskeho etnika vo vzťahu k epidemiológii CKD/ESRD (kapitoly 
4-5); a c) na potenciálne riziko rozvoja CKD (kapitola 6) a na analýzu 
nepriaznivej prognózy CKD (kapitola 7). 
Kapitola 1 predstavuje hlavné témy štúdie obsiahnuté v piatich 
výskumných otázkach a zároveň formuluje základný model vyjadrujúci 
vzťah epidemiológie, rizikových faktorov a dôsledkov CKD/ESRD. 
Kapitola 2 uvádza informácie o klinickom súbore, dátových zdrojoch 
a štatistických analýzach použitých v kapitolách 3-7. 
V kapitole 3 sa opisuje trend výskytu ESRD na Slovensku 
v uplynulých desaťročiach a hodnotí demografický vývoj aj z európskeho 
pohľadu. Ukázalo sa, že za posledných desať rokov nedošlo na Slovensku 
k signifikantným zmenám incidencie a prevalencie ESRD v detskej 
populácii. V porovnaní so susednými krajinami a s európskym priemerom 
sme nepreukázali žiadne významné rozdiely v incidencii, zatiaľ čo 
prevalencia bola na Slovensku výrazne nižšia než európsky priemer. 
Kapitola 4 pojednáva o rómskom pôvode ako riziku pre rozvoj 
ESRD. Výskyt ESRD bol významne častejší v populácii Rómov všetkých 
vekových skupín vrátane dospelých. Relatívne riziko (RR) výskytu ESRD 
v populácii Rómov bolo 1,34 (v porovnaní s väčšinovou populáciou). 
Po vekovej štandardizácii bolo toto RR dokonca 2,85. Zvýšené riziko 
pre ESRD (slovenských) Rómov môže byť dôsledkom ich genetickej 
náchylnosti k zlyhaniu obličiek ako aj dôsledkom horšieho manažmentu 
ďalších rizikových faktorov pre ESRD, najmä v súvislosti so sociálno-
ekonomickou situáciou. 
Kapitola 5 študovala etnické rozdiely epidemiológie včasnejších 
štádií CKD (1.-4. štádium). Preukázali sme, že Rómovia sú relatívne málo 
zastúpení medzi pacientami s CKD 1.-4. štádia, čo je v kontraste s ich 
nepomerne vysokým zastúpením v skupine detí s terminálnym zlyhaním 
(CKD 5. štádia t.j. ESRD). V prípade niektorých pomerne vzácnych 
nefropatií boli Rómovia zastúpení častejšie aj medzi pacientami CKD 1.-4. 
štádia. 
V kapitole 6 sú sumarizované výsledky prospektívneho sledovania 
detí s jednou funkčnou obličkou (SFK) so zreteľom na riziko renálneho 
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poškodenia. Zistili sme, že v značnej časti pacientov so SFK sú prítomné 
známky poškodenia obličiek už v detskom veku, a to najmä u detí 
s anomáliami štruktúry SFK. 
V kapitole 7 sme preskúmali výskyt kardiovaskulárnych dôsledkov 
CKD/ESRD, najmä prítomnosť hypertrofie ľavej komory (LVH) pred a po 
transplantácii obličky. Ukázalo sa, že LVH môže pretrvávať aj po úspešnej 
transplantácii obličky, a že LVH podlieha intraindividuálnym variáciám, 
čo sa sčasti dá vysvetliť nedostatočnou mierou kontroly rizikových 
faktorov, predovšetkým hypertenzie. 
V kapitole 8 diskutujeme o celkových výsledkoch práce, 
vyzdvihujeme silné stránky a kriticky analyzujeme stránky slabé, 
zdôrazňujeme dôsledky pre klinickú prax a ponúkame nové možnosti 
ďalšieho výskumu. Súhrnne možno konštatovať, že výskyt ESRD u detí 
sa v priebehu uplynulého desaťročia na Slovensku výrazne nezmenil, 
pričom rómsky pôvod je spojený s horším vývojom a progresiou CKD. 
Klinicky dôležitým zistením je výskyt známok incipientného poškodenia 
obličiek u značnej časti detí so SFK a pretrvávanie LVH aj po úspešnej 
transplantácii obličky.
Budúci výskum by sa mal zamerať na analýzu príčin zvýšeného 
rizika CKD/ESRD v populácii Rómov, a to predovšetkým u jedincov 
z marginalizovaných rómskych osád. Objasnenie mechanizmov 
potencujúcich riziko rýchlejšej progresie chronických nefropatií u Rómov 
môže viesť k cielenejším intervenciám. Osobitú pozornosť si zaslúži 
problematika SFK a pretrvávanie kardiovaskulárneho bremena u detí 
s transplantovanou obličkou. Táto práca okrem iného dokumentuje, 
že významný benefit pre zdravie populácie možno dosiahnuť lepšou 
prevenciou a starostlivosťou o ochorenia obličiek u detí.
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